<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        7-6063-25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1981
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ENDOXAN SUGAR COATED TABLET 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CYCLOPHOSPHAMIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        40.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PRASFARMA S.L." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PRASFARMA S.L.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Deutschland GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Throughout this leaflet, ENDOXAN Tablets 50 mg will be called Cyclophosphamide.</strong></p><p><strong>Important things to know about Cyclophosphamide</strong></p><p>Your doctor has prescribed Cyclophosphamide because you have cancer that can be treated.</p><p>Cyclophosphamide is a medicine that kills cancer cells but, as a result, also attacks normal cells. It can therefore have a number of side effects. Your doctor will not give you Cyclophosphamide unless he or she thinks that your cancer is more of a risk to you than any possible side effects. Your doctor will check you regularly and treat any side effects where possible.</p><p>Cyclophosphamide:</p><p>- will reduce your blood cell count, which may make you feel tired and be more likely to get infections.</p><p>can affect your kidneys and bladder. You may be given another medicine called Mesna to help prevent any damage. If you notice blood in your urine, tell your doctor immediately.</p><p>- like most anti-cancer or chemotherapy medicines, you may lose your hair (anything from thinning to total loss), although it should start to grow back once your treatment has finished.&nbsp; It may also make you feel sick or be sick.&nbsp; Your doctor can give you advice or medicines to help.</p><p>- Men or women should not have a child during treatment with Cyclophosphamide or for at least 6 months after treatment. You should use an effective contraceptive. Ask your doctor for advice.</p><p><strong>Now read the rest of this leaflet. </strong>It includes other important information on the use of Cyclophosphamide that might be especially important for you.</p><p>&nbsp;</p><p>Cyclophosphamide<strong> </strong>is a cytotoxic drug or anti-cancer drug. It works by killing cancer cells, this is sometimes called &lsquo;chemotherapy&rsquo;.</p><p>It is used to treat lots of different cancers. Cyclophosphamide is often used together with other anti-cancer drugs or radiotherapy. Occasionally, some doctors may prescribe Cyclophosphamide for other conditions not related to cancer, your doctor will tell you if this applies to you</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Cyclophosphamide if:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever had an allergic reaction to the active ingredient or any of the other ingredients (listed in Section 6). &nbsp;An allergic reaction can include shortness of breath, wheezing, rash, itching or swelling of the face and lips</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your bone marrow is not working properly (especially if you have previously had chemotherapy or radiotherapy). &nbsp;You will have blood tests to check how well your bone marrow is working</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a urinary tract infection, which can be recognised as pain when passing urine (cystitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you currently have any infections</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever had kidney or bladder problems as a result of previous chemotherapy or radiotherapy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a condition which decreases your ability to urinate (Urinary outflow obstruction).</p><p>&nbsp;</p><p><strong>Warnings and precautions:</strong></p><p>Talk to your doctor, pharmacist or nurse before taking Cyclophosphamide if:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are already having, or have recently had, radiotherapy or chemotherapy</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have diabetes</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have liver or kidney problems. Your doctor will check how well your liver and kidneys are working by doing a blood test</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have had your adrenal glands removed</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have heart problems or have had radiotherapy in the area of your heart</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have poor general health or are frail</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are elderly.</p><p>&nbsp;</p><p><strong>Take special care with Cyclophosphamide</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can have effects on your blood and immune system</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood cells are made in your bone marrow. Three different types of blood cell are made:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red blood cells, which carry oxygen around your body</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; white blood cells, which fight infection, and</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; platelets, which help your blood to clot.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After taking Cyclophosphamide, your blood count of the three types of cells will drop. This is an unavoidable side effect of Cyclophosphamide. Your blood count will reach its lowest level about 5 to 10 days after you start taking Cyclophosphamide and will stay low until a few days after you finish the course. Most people recover to a normal blood count within 21 to 28 days. If you have had a lot of chemotherapy in the past, it may take a little longer to return to normal.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You may be more likely to get infections when your blood count drops. Try to avoid close contact with people who have coughs, colds and other infections.&nbsp; Your doctor will treat you with appropriate medicine if they think you have, or are at risk, of an infection.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will check that the number of red blood cells, white blood cells and platelets is high enough before and during your treatment with Cyclophosphamide. They may need to reduce the amount you are given or delay your next dose.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can affect wound healing.&nbsp; Keep any cuts clean and dry, and check they are healing normally.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is important to keep your gums healthy, as mouth ulcers and infections can occur. Ask your doctor about this if you are unsure.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can damage the lining of your bladder, causing bleeding into your urine and pain on urination. Your doctor knows this can happen and, if necessary, he or she will give you a medicine called Mesna which will protect your bladder.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mesna can either be given to you as a short injection, or mixed into the drip solution with your Cyclophosphamide, or as tablets.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; More information on Mesna can be found in the Patient Information Leaflet for Mesna Injection and Mesna tablets.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most people having Cyclophosphamide with Mesna do not develop any problems with their bladder, but your doctor may want to test your urine for the presence of blood using a &lsquo;dipstick&rsquo; or microscope.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you notice that you have blood in the urine, you must tell your doctor straight away as they may need to stop giving you cyclophosphamide.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cancer medicines and radiation therapy can increase the risk of you developing other cancers; this can be a number of years after your treatment has stopped.&nbsp; Cyclophosphamide has an increased risk of causing cancer in the area of your bladder.&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can cause damage to your heart or affect the rhythm of it beating.&nbsp; This increases with higher doses of Cyclophosphamide, if you are being treated with radiation or other chemotherapy medicines or if you are elderly. &nbsp;Your doctor will monitor your heart closely during treatment.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can cause inflammation or scarring in your lungs.&nbsp; This can occur more than six months after your treatment.&nbsp; If you start having difficulty breathing tell your doctor straight away.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can have life threatening effects on your liver.&nbsp; If you have sudden weight gain, liver pain and jaundice tell your doctor straight away.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair thinning or baldness can occur.&nbsp; Your hair should grow back normally though it may be different in texture or colour.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can make you feel sick or be sick.&nbsp; This can last for about 24 hours after taking Cyclophosphamide. You may need to be given medicines to stop feeling or being sick. Ask your doctor about this.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Using other medicines and treatments</strong></p><p>Tell your doctor or nurse if you are taking or have recently taken any other medicines, including medicines you have bought yourself.&nbsp; In particular, tell them about the following medicines or treatments as they may not work well with Cyclophosphamide:</p><p>&nbsp;</p><p>The following medicines can reduce how effective Cyclophosphamide is:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; aprepitant (used to prevent being sick)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bupropion (an anti-depressant)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; busulfan, thiotepa (used to treat cancer)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ciprofloxacin, chloramphenicol (used to treat bacterial infections)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluconazole, itraconazole (used to treat fungal infections)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prasugrel (used to thin the blood)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sulfonamides, such as sulfadiazine, sulfasalazine, sulfamethoxazole (used to treat bacterial infections)</p><p>&nbsp;</p><p>The following medicines can increase the toxicity of Cyclophosphamide:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allopurinol (used to treat gout)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; azathioprine (used to reduce the activity of the immune system)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chloral hydrate (used to treat insomnia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cimetidine (used to reduce stomach acid)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disulfiram (used to treat alcoholism)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glyceraldehyde (used to treat warts)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; protease inhibitors (used to treat viruses)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ondansetron (used to prevent being sick)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that increase liver enzymes such as:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rifampicin (used to treat bacterial infections)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; carbamazepine, phenobarbital, phenytoin (used to treat epilepsy)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; St. John&rsquo;s wort (a herbal remedy for mild depression)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids (used to treat inflammation)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your blood cells and immunity</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ACE inhibitors (used to treat high blood pressure).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; natalizumab (used to treat multiple sclerosis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; paclitaxel (used to treat cancer)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thiazide diuretics such as hydrochlorothiazide or chlortalidone (used to treat high blood pressure or water retention)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; zidovudine&nbsp; (used to treat viruses)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Clozapine (used to treat symptoms of some psychiatric disorders)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your heart</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anthracyclines such as bleomycin, doxorubicin, epirubicin, mitomycin (used to treat cancer)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cytarabine, pentostatin, trastuzumab (used to treat cancer)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; radiation in the area of your heart</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your lungs</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amiodarone (used to treat irregular heart beat)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; G-CSF, GM-CSF hormones (used to increase white blood cell numbers after chemotherapy)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your kidneys</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amphotericin B (used to treat fungal infections)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indomethacin (used to treat pain and inflammation)</p><p>&nbsp;</p><p>Other medicines that can affect or be affected by Cyclophosphamide include:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; etanercept (used to treat rheumatoid arthritis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; metronidazole (used to treat bacterial or protozoal infections)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tamoxifen (used to treat breast cancer)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bupropion (used to help stop smoking)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; coumarins such as warfarin (used to thin the blood)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cyclosporine (used to reduce the activity of the immune system)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; succinylcholine (used to relax muscles during medical procedures)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; digoxin, &beta;-acetyldigoxin (used to treat heart conditions)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vaccines</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; verapamil (used to treat high blood pressure, angina or irregular heart beat)</p><p>&nbsp;</p><p><strong>Cyclophosphamide with food and drink</strong></p><p>Drinking alcohol can increase the nausea and vomiting caused by Cyclophosphamide.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>Do not become pregnant while taking Cyclophosphamide.&nbsp; This is because it can cause miscarriage or damage your unborn baby. Tell your doctor if you are pregnant, think you might be pregnant or are trying to become pregnant.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Men or women should not try to have a child during or for at least 6 to 12 months after treatment. You should use an effective contraceptive. Ask your doctor for advice.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can affect your ability to have children in the future.&nbsp; Talk to your doctor about freezing sperm samples or eggs before your treatment starts.</p><p>&nbsp;</p><p>Do not breast-feed while being treated with Cyclophosphamide. Ask your doctor for advice.</p><p>&nbsp;</p><p><strong>Driving or using machines</strong></p><p>Some of the side effects of treatment with Cyclophosphamide might affect your ability to drive and use machines safely. Your doctor will decide if it is safe for you to do so.</p><p>&nbsp;</p><p><strong>What to do if you see a different doctor, or have to go to hospital</strong></p><p>If you see any other doctor or have to go to hospital for any reason, tell them what medicines you are taking. Do not take any other medicines unless your doctor knows you are taking Cyclophosphamide</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Taking this medicine</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide Tablets are to be taken by mouth. Do not chew them.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are also having Mesna, your doctor will tell you how much you need to drink.</p><p>You should take your tablets with enough liquid to make them easy to swallow.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide is often given with other anti-cancer drugs or radiotherapy.</p><p>&nbsp;</p><p><strong>The usual dose</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will decide how much of the medicine you need and when you should take it.&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The amount of Cyclophosphamide you will need to take depends on:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the type of illness you have</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; how big you are (a combination of your height and weight)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your general health</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; whether you are being given other anti-cancer drugs or having radiotherapy.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual dose is between 100&nbsp;mg (2 tablets) and 300&nbsp;mg (6 tablets) per day. You can take all of one day&#39;s tablets together, but you should try to take them about the same time each day, preferably in the morning. If you are not sure how to take your tablets, ask your doctor or pharmacist.</p><p>&nbsp;</p><p>Cyclophosphamide is usually taken for several days in a row as a course, and then there is a break (a period when no tablets are taken) before the next course. Sometimes you may need to take different numbers of tablets on alternate days, for instance, 3 tablets one day and 4 the next.</p><p>&nbsp;</p><p>Your doctor may need to change the amount of medicine you are given and monitor you more closely if you:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have problems with your liver or kidneys</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are elderly.</p><p>&nbsp;</p><p><strong>If you forget to take Cyclophosphamide</strong></p><p>If you forget to take your Cyclophosphamide:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you should take them as soon as you remember, if it is on the same day.&nbsp; If you have forgotten to take a whole day&#39;s tablets, then you should talk to your doctor.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Never take more tablets in one day than you were meant to &ndash; so never take two days worth of tablets on the same day in order to &lsquo;catch up&rsquo;.</p><p>&nbsp;</p><p><strong>If you take too much Cyclophosphamide</strong></p><p>In the event of an overdose, or if a child swallows any of your tablets, talk to your doctor or local hospital emergency department immediately. Hospital admission for special treatment may be needed</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Cyclophosphamide can cause side effects, although not everybody gets them. Side effects can sometimes occur after ending the treatment. The following side effects may happen with this medicine.</p><p><strong>Tell your doctor straight away, and go to hospital immediately if you notice any of the following serious side effects:</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions, signs of this would be shortness of breath, wheezing, rash, itching or swelling of the face and lips (hypersensitivity). Severe allergic reactions could lead to difficulty in breathing or shock, with a possible fatal outcome (anaphylactic shock, anaphylactic/ anaphylactoid reaction)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; getting bruises without knocking yourself, or bleeding from your gums. This may be a sign that the platelet levels in your blood are getting too low&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a lowering of your white blood cell count - your doctor will check this during your treatment. It will not cause any signs, but you will be more likely to get infections. If you think you have an infection (a high temperature, feeling cold and shivery, or hot and sweaty, or any signs of infection such as a cough, or stinging on passing water) you may need antibiotics to fight infections because your blood count is lower than usual</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood in your urine, pain while passing urine, or less urine being passed (haemorrhagic cystitis, haematuria)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of your intestines or bowel which may resulting in bleeding (hemorrhagic enterocolitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits (convulsions)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life threatening conditions which cause rash, ulcers, sore throat, fever, conjunctivitis, separation of skin layers (toxic epidermal necrolysis, Stevens-Johnson syndrome). Swelling, numbness, red lumps and peeling of skin on the hands and feet (Palmar-plantar erythrodysesthesia syndrome)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life threatening decrease in the abilities of your kidney to adequately remove toxins and waste products from the blood (kidney failure). These changes to the tissues within your kidney can prevent them from working correctly, and induce kidney failure (renal tubular necrosis, renal tubular disorder)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pneumonia. Signs of this could be chest pain when you breathe or cough, confusion, coughing, fever, sweating and chills, fatigue, shortness of breath, nausea, vomiting or diarrhoea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe infection spreading through the blood which may lead to a dangerous drop in blood pressure with a possible fatal outcome (sepsis, shock)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effects on the brain (encephalopathy), signs of this can be problems in thinking or concentrating, reduced alertness, changes in personality, tiredness, fits, muscle twitching, and shaking</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a syndrome called reversible posterior leukoencephalopathy syndrome, which can cause swelling of the brain, headache, confusion, fits and loss of sight</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart attack (myocardial infarction)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in your hearts ability to pump enough blood around your body which may be life threatening (cardiogenic shock, heart failure or cardiac arrest)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life-threatening decrease of your lungs ability to transfer oxygen in to your blood (respiratory failure)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a build-up of toxins in the body due to liver failure (hepatotoxicity). This may affect the brain causing confusion, reduced consciousness or coma (hepatic encephalopathy)</p><p>&nbsp;</p><p><strong>Tell your doctor straight away, if you notice any of the following serious side effects:</strong></p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; haemolytic uremic syndrome - a condition causing abnormal break down of the red blood cells, decreased numbers of platelets in the blood and kidney failure</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cancer of your blood (leukaemia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cancer of the bone marrow (myelodysplastic syndrome)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the brain due to too much water in your blood (water intoxication). Signs of this can be headache, changes in personality or behaviour, confusion, drowsiness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; formation of small blood clots in your blood vessels disrupting the normal blood flow around your body (disseminated intravascular coagulation)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood clot in the lungs which causes chest pain and breathlessness (pulmonary embolism)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood clot, usually in a leg, which causes pain swelling or redness (venous thrombosis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood levels of sodium which can cause tiredness and confusion, muscle twitching, fits and coma (hyponatremia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tummy discomfort or severe tummy and back pain, this may be caused by inflammation of the pancreas (acute pancreatitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood sugar levels which can cause thirst, tiredness and irritability (hyperglycaemia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood sugar levels which can cause confusion and sweating (hypoglycaemia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effects on the spinal cord (Myelopathy), which can cause numbness, weakness and tingling in the hands, loss of motor skills disease of the heart muscle (cardiomyopathy); inflammation of the tissues in or around your heart (myocarditis, pericarditis); build up of fluid in the sac around your heart (pericardial effusion). Increased pressure from this fluid can stop the heart filling properly (cardiac tamponade); abnormal ECG heart tracing (Electrocardiogram QT prolonged) &ndash; These could be considered causes of arrhythmia</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your heart rhythm (arrhythmia) which may be noticeable (palpitations):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irregular heart beat (fibrillation)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; faster heart beat (tachycardia), which may be life threatening (ventricular tachycardia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slower heart beat (bradycardia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood clot in the lungs which causes chest pain and breathlessness (pulmonary veno-occlusive disease)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; scarring of the lungs which causes shortness of breath (pulmonary fibrosis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; conditions causing inflammation of the lungs which can cause breathlessness, cough and raised temperature or scarring of the lungs (pneumonitis, acute respiratory distress syndrome, obliterative bronchiolitis, organizing pneumonia, alveolitis allergic)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluid in or around the lungs (pulmonary oedema, pleural effusion)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased blood pressure in the lungs which can cause shortness of breath, fatigue, cough, angina, fainting, peripheral oedema (pulmonary hypertension)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal muscle breakdown which can lead to kidney problems (rhabdomyolysis)</p><p><strong>&nbsp;</strong></p><p><strong>Other possible side effects, listed by frequency, may be:</strong></p><p><strong>&nbsp;</strong></p><p><strong>Very common: </strong>may effect more than 1 in 10 people</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduction in the effectiveness of your immune system (immunosuppression)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss (alopecia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain and difficultly passing urine (cystitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very pale, lethargic and tired. This may be a sign of low red blood cells (anaemia). Usually, no treatment is required, your body will eventually replace the red blood cells. If you are very anaemic, you may need a blood transfusion</p><p>&nbsp;</p><p><strong>Common: </strong>may effect up to 1 in 10 people</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased risk and severity of bacterial, fungal, viral, protozoal or parasitic infections due to the effect of cyclophosphamide on your immune system</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reactivation of infections you have had before (latent infections)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased levels of certain proteins produced by your liver called enzymes. Your doctor will do blood tests to test for these</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the bladder lining which causes pain, bleeding, blood in the urine, reduced urine flow (haemorrhagic cystitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the linings of your body cavities (mucosal inflammation)</p><p>&nbsp;</p><p><strong>Uncommon: </strong>may effect up to 1 in 100 people</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite (anorexia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reddening of the skin (flushing) which may be accompanied by feeling hot or sweating (hot flushing)</p><p>&nbsp;</p><p><strong>Rare: </strong>may effect up to 1 in 1,000 people</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; secondary tumours in various parts of the body, often in the area of the bladder</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dehydration</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blurring, reduction or loss of sight</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in colour of your fingernails and skin.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of this skin which may cause rash, blisters, itching, sores, oozing and scarring (dermatitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; absence of menstrual periods (amenorrhea)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain</p><p>&nbsp;</p><p><strong>Very rare: </strong>may effect up to 1 in 10,000 people</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in the release of antidiuretic hormone from the pituitary gland. This affects the kidneys causing the low levels of sodium in your blood (hypernatremia) and water retention</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; accumulation of fluid in the body (water retention), which may been seen as fluid beneath the skin or swelling in you limbs</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick and being sick (nausea, vomiting)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation or diarrhoea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ulcers in the lining of your digestive system (mucosal ulceration)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the lining of your mouth including ulcers (stomatitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; confusion</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ulceration or scaring (fibrosis) of the bladder</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the eye (conjunctivitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; eye oedema (swelling)</p><p>&nbsp;</p><p><strong>Unknown: </strong>frequency cannot be estimated from the available data</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes to your metabolism caused by the breakdown of the dying cancer cells (Tumour lysis syndrome)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of your intestines or bowel which may resulting in bleeding (enteritis, cecitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bleeding in your stomach or intestines (gastrointestinal haemorrhage)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation which causes abdominal pain or diarrhoea (colitis) swelling of the glands in your neck (parotid gland inflammation)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a disorder of the nerves which can cause weakness, tingling or numbness (peripheral neuropathy). This could be in more than one set of nerves (polyneuropathy)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain from your nerves, which can also feel like an aching or burning sensation (neuralgia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tingling or numbness, often in the hands or feet (paresthesia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shaking (tremor)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your sense of touch (dysesthesia) or loss of sensation (hypoesthesia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your sense of taste (dysgeusia) or loss of taste (hypogeusia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your sense of smell (parosmia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased tear formation (lacrimation)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; deafness or hearing impairment</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ringing in the ears (tinnitus)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the blood vessels (vasculitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced blood supply to your hands and feet (peripheral ischemia). This may cause pain, weakness, numbness, ulcers, changes in skin colour or temperature</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in breathing or wheezing (bronchospasm)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath (dyspnea)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease levels of oxygen in your body (hypoxia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blocked or runny nose</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain at the back of your throat</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased liver size (hepatomegaly)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of the skin or whites of the eyes (jaundice)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blockage of the small veins in your liver (veno-occlusive liver disease) which can cause weight gain, increased liver size, pain and jaundice</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; conditions causing inflammation of the liver which can cause jaundice, weight loss and malaise (hepatitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disruption of the formation of bile by the liver which can cause itchiness, jaundice, pale coloured stools, dark urine (cholestasis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a build-up of fluid in the abdomen causing swelling of the tummy and shortness of breath (ascites)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dark red raised itchy rash (urticaria)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; redness and blistering of the skin appearing months or years after treatment (radiation recall dermatitis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, red rash which can develop in to sores (erythema multiforme)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; excessive sweating (hyperhidrosis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the face</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching (pruritus)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serious illness which causes thickening of the skin and the connective tissue in your internal organs (scleroderma)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle spasms</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle pain (myalgia) or joint pain (arthralgia)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; damage to the kidneys by toxins in the blood (toxic nephropathy)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glucose in the urine (nephrogenic diabetes insipidus)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the urethra which causes pain and bleeding (haemorrhagic ureteritis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; death of the cells and tissues (necrosis)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the size of the bladder (bladder contracture)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes to the cells in the lining of your bladder</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in the levels of creatinine or urea nitrogen in your blood. Your doctor will do blood tests to test for these</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; premature labour</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infertility. Sperm production in men and egg production in women may be reduced or stop. In some cases this can be permanent</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduced frequency of menstrual periods (oligomenorrhea)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in testicle size (testicular atrophy)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the hormone oestrogen in the blood</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in the hormone gonadotrophin in the blood</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; use in young patients may result in some impairments of future fertility</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduction in growth, deformity or death of a foetus while in the womb</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; toxic effects on the foetus such as myelosuppression and gastroenteritis</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life threatening failure of multiple organs such as heart, lungs, kidney, liver (see symptoms throughout section 4)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; general physical deterioration</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flu-like symptoms such as headache, fever, chills, joint and muscle pain, weakness, tiredness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; injection site reaction.</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:655px"><tbody><tr><td style="vertical-align:top"><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:659px"><tbody><tr><td><p>Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Cyclophosphamide after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 25&ordm;C. Store in the original container.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via wastewater or household waste. If you have any medicine left over, take it back to your pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What</strong><strong> Cyclophosphamide contains</strong></p><p>The active substance is Cyclophosphamide and each tablet contains 50&nbsp;mg.</p><p>Other ingredients are: maize starch, lactose monohydrate, calcium hydrogen phosphate, talc, magnesium stearate, gelatine, glycerol, sucrose, titanium dioxide (E171), calcium carbonate, macrogol, colloidal anhydrous silica, povidone, carmellose sodium, polysorbate 20, montan glycol wax.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cyclophosphamide Tablets are white, round, coated tablets with a white core. There are 10 tablets in a blister strip and 5 blister strips in a box. Pack with 50 coated tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder: </strong></p><p>Baxter Oncology GmbH</p><p>Kantstrasse 2,</p><p>33790 Halle, Germany</p><p><strong>Manufactured by: </strong></p><p>Prasfarma S.L., Spain</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in January 2019.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>خلال هذه النشرة، ستسمى أقراص إندوكسان 50 ملغ بــ&nbsp; <u>سايكلوفوسفامايد</u>.</strong></p><p dir="RTL"><strong>معلومات هامة يجب معرفتها عن سايكلوفوسفامايد</strong></p><p dir="RTL">طبيبك وصف سايكلوفوسفامايد لأن لديك سرطان يمكن علاجه.</p><p dir="RTL">سايكلوفوسفامايد هو دواء يقتل الخلايا السرطانية ولكن، نتيجة لذلك، يهاجم الخلايا الطبيعية أيضا. وبالتالي يمكن أن يكون له عدد من الآثار الجانبية. لن يعطيك طبيبك سايكلوفوسفامايد إلا إذا كان يعتقد أن السرطان الذي لديك هو أكثر خطراً بالنسبة لك من أي آثار جانبية محتملة. سيقوم طبيبك بفحصك بانتظام ومعالجة أي آثار جانبية حيثما أمكن.</p><p dir="RTL">سايكلوفوسفامايد:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوف يقلل من عدد خلايا الدم، والتي قد تجعلك تشعر بالتعب وتكون أكثر عرضة للالتهابات.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يؤثر على الكلى والمثانة. قد يعطى لك دواء آخر يسمى (يوروميتيكسان &quot;ميسنا&quot;) للمساعدة في منع أي تلف للخلايا. إذا لاحظت وجود دم في البول، أخبر طبيبك فورا.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثل معظم الأدوية المضادة للسرطان أو العلاج الكيميائي، قد تفقد شعرك (من التساقط الخفيف إلى التساقط الكلي للشعر)، مع ذلك يبدأ الشعر في النمو مرة أخرى بمجرد الانتهاء من العلاج. قد يجعلك تشعر بالتعب والإعياء. يمكن لطبيبك أن يقدم لك المشورة أو الأدوية للمساعدة.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبغي للرجال والنساء عدم محاولة الإنجاب أثناء العالج بـ سايكلوفوسفامايد و لمدة 6 أشهر على الأقل بعد إنتهاء العلاج. يجب عليك استخدام وسائل منع الحمل فعالة. إسأل طبيبك للحصول على المشورة.</p><p dir="RTL"><strong>الآن أكمل قراءة بقية النشرة</strong>. والتي تتضمن معلومات أخرى عن استخدام سايكلوفوسفامايد التي قد تكون ذات أهمية خاصة بالنسبة لك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">سايكلوفوسفامايد هو دواء سام للخلايا أو دواء مضاد للأورام السرطانية. وهو يعمل عن طريق قتل الخلايا السرطانية، وهذا ما يسمى أحيانا &quot;العلاج الكيميائي&quot;.</p><p dir="RTL">يتم استخدامه لعلاج الكثير من أنواع السرطان المختلفة. غالبًا ما يستخدم السيكلوفوسفاميد مع الأدوية المضادة للسرطان أو العلاج الإشعاعي. في بعض الأحيان ، قد يصف بعض الأطباء سايكلوفوسفامايد لحالات أخرى لا علاقة لها بالأورام السرطانية، وسوف يخبرك طبيبك إذا كان هذا ينطبق عليك.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول سايكلوفوسفامايد اذا</strong></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك في اي وقت مضى حساسية مفرطة معروفة من سايكلوفوسفامايد أو أي من مكونات الدواء الأخرى (المدرجة في القسم 6). يمكن أن يكون رد الفعل التحسسي على شكل ضيق في التنفس، صفير، طفح جلدي، حكة أو تورم في الوجه والشفتين.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من ضعفٍ شديد بوظائف النخاع العظمي (وخاصة عند المرضى الذين تمت معالجتهم من قبل بعوامل مضادة للأورام أو المعالجة الإشعاعية). سيتم اجراء تحاليل الدم اللازمة للتحقق من مدى فعالية عمل النخاع العظمي لديك.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من التهاب في المثانة ، والتي يمكن التعرف عليها بالشعور بآلام عند التبول (التهاب المثانة).</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مصاب حاليا بأي نوع من أنواع الإلتهابات.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خضعت سابقا للعلاج الكيميائي او الإشعاعي وحدث لديك مشاكل في الكلى او المثانة نتيجة للعلاج.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعاني من انخفاض في القابلية للتبول (انسداد في مجرى البول).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي أو الممرضة قبل تناول سايكلوفوسفامايد إذا:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تخضع بالفعل أو خضعت مؤخرًا لعلاج إشعاعي أو كيميائي</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت مصاباً بداء السكري.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كانت لديك مشكلات في الكبد أو الكلى. سيقوم الطبيب باجراء تحاليل الدم اللازمة للتحقق من مدى فعالية عمل وظائف الكبد والكلى لديك.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خضعت لاستئصال الغدد الكظرية</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كانت لديك مشكلات في القلب أو تلقيت علاجًا إشعاعيًا في محيط منطقة الصدر.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من ضعف في الصحة العامة أو ضعف البنية.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت متقدم في السن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يجب الاهتمام بصورة خاصة مع سايكلوفوسامايد</strong></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سايكلوفوسامايد يمكن ان يؤثر على الدم وعلى الجهاز المناعي لديك.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلايا الدم تتكون في النخاع العظمي لديك. هناك ثلاث أنواع من خلايا الدم:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلايا الدم الحمراء، التي تنقل الأكسجين لجميع أنحاء الجسم.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلايا الدم البيضاء، التي تدافع عن الجسم من الإلتهابات.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصفيحات الدموية، التي تساعد على تجلط الدم.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعد تناول سايكلوفوسفامايد، تعداد خلايا الدم لديك سوف ينخفض. هذا الأثر الجانبي للسايكلوفوسفامايد لا يمكن تجنبه. تعداد خلايا الدم سوف يصل لأقل مستوى له في خلال ٥ الى ١٠ أيام بعد البدء في تناول سايكلوفوسفامايد و سوف يبقى منخفضاً لبضعة أيام بعد الإنتهاء من دورة العلاج. في معظم الحالات يعود تعداد الدم الطبيعي في غضون 21 إلى 28 يوما. إذا كان لديك الكثير من جلسات العلاجات الكيميائي في الماضي، قد يستغرق وقتا أطول قليلا للعودة إلى وضعها الطبيعي.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تكون أكثر عرضة للإصابة بالعدوى عندما ينخفض تعداد الدم لديك. حاول تجنب الاتصال الوثيق مع الأشخاص الذين يعانون من السعال ونزلات البرد والإلتهابات الأخرى. سيقوم طبيبك بمعالجتك بالدواء المناسب إذا اعتقدت أنك مصاب أو معرض لخطر الإصابة بالعدوى.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيتحقق طبيبك من أن عدد خلايا الدم الحمراء وخلايا الدم البيضاء والصفائح الدموية مرتفع بما فيه الكفاية قبل وأثناء العلاج مع سايكلوفوسفامايد. قد تحتاج إلى تقليل الجرعة أو تأخير الجرعة التالية.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يؤثر سايكلوفوسفامايد على إلتئام الجروح. يجب عليك إبقاء الجروح نظيفة وجافة، وتحقق دائماً من أنها تشفى وتتعافى بشكل طبيعي.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من المهم الحفاظ على صحة اللثة، حيث أنه من الممكن حدوث تقرحات والتهابات في الفم. اسأل طبيبك عن ذلك إذا لم تكن متأكدا.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سايكلوفوسفامايد يمكن أن يضر ببطانة المثانة، مما يتسبب في نزف في البول والشعور بألم عند التبول. الطبيب يعرف أن هذا يمكن أن يحدث، وإذا لزم الأمر، سوف يعطيك دواء يسمى &nbsp;(يوروميتيكسان &quot;ميسنا&quot;) الذي من شأنه حماية المثانة.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يعطى دواء (يوروميتيكسان &quot;ميسنا&quot;) لك عن طريق الحقن المباشر، أو يتم خلطه في المحلول مع سايكلوفوسفامايد، أو على شكل أقراص بالفم.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المزيد من المعلومات عن (يوروميتيكسان &quot;ميسنا&quot;) يمكن العثور عليها في نشرة معلومات المريض الخاصة بـ (يوروميتيكسان &quot;ميسنا&quot;) حقن وأقراص.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; معظم الناس الذين يتناولون سايكلوفوسفامايد مع (يوروميتيكسان &quot;ميسنا&quot;) لا تتطور لديهم أية مشاكل في المثانة، ولكن طبيبك قد يرغب في إجراء تحليل للبول لوجود دم باستخدام المجهر.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا لاحظت وجود دم في البول، يجب إخبار الطبيب على الفور لأنه قد يحتاج إلى وقف سايكلوفوسفامايد.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن لأدوية العلاج الكيميائي و الإشعاعي أن يزيد من خطر الإصابة بأنواع أخرى من الأورام السرطانية؛ وهذا يمكن أن يكون بعد عدة سنوات من توقف العلاج. سايكلوفوسفامايد يمكن أن يزيد خطر التسبب في الأورام السرطانية في منطقة المثانة.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سايكلوفوسفامايد يمكن أن يسبب ضرر للقلب أو يؤثر على معدل نبضات القلب. هذا يزيد مع جرعات أعلى من سايكلوفوسفامايد، وإذا كنت تُعالج بالإشعاع أو العلاجات الكيميائية الأخرى أو إذا كنت من كبار السن. طبيبك سوف يراقب قلبك عن كثب خلال فترة العلاج.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سايكلوفوسفامايد يمكن أن يسبب التهاب أو ندب في الرئتين. يمكن أن يحدث هذا بعد أكثر من ٦ أشهر بعد العلاج. إذا شعرت بصعوبة في التنفس أخبر الطبيب على الفور.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سايكلوفوسفامايد يمكن أن يكون له آثار شديدة على الكبد. إذا حدث لديك زيادة وزن مفاجئ، أو ألم في الكبد أو اليرقان (الإصفرار) أخبر الطبيب على الفور.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يحدث تساقط في الشعر أو صلع. شعرك سوف ينمو مرة أخرى بشكل طبيعي على الرغم من أنه قد يكون مختلف في الملمس أو اللون.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سايكلوفوسفامايد يمكن أن يجعلك تشعر بالغثيان والقيء. وهذا يمكن أن يستمر لمدة ٢٤ ساعة بعد أخذ سايكلوفوسفامايد. قد تحتاج إلى تناول أدوية لوقف الشعور بالغثيان والقيء. إسأل الطبيب حول هذا الموضوع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>استخدام أدوية أو علاجات أخرى مع سايكلوفوسفامايد</strong></p><p dir="RTL">يُرجى إخبار طبيبك الخاص أو الصيدلي إذا كنت تتناول أو تناولت أي أدوية أخرى في الفترة الأخيرة، بما في ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية. بشكل خاص، أخبر الطبيب أو الصيدلي حول ما إذا كنت تستخدم الأدوية او العلاجات التالية؛ حيث أنه ربما لا تكون لديها الفعالية المرجوة مع سايكلوفوسفامايد:</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التالية يمكن أن تقلل فعالية سايكلوفوسفامايد:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أبريبيتانت (يستخدم لمنع الشعور بالغثيان والقيء)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بيبروبيون (مضاد للإكتئاب)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بوسلفان، ثيوتبا ( أدوية لمعالجة الأورام السرطانية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيبروفلوكساسين، كلورامفينيكول (تستعمل لعلاج الالتهابات البكتيرية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فلوكونازول، ايتراكونازول (تستعمل لعلاج الالتهابات الفطرية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; براسوجرل (يستعمل لسيولة الدم)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السلفوناميدات، مثل سلفاديازين، سلفاسلازين، و سلفاميثوكسازول (تستعمل لعلاج الالتهابات البكتيرية)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التالية يمكن أن تزيد من سميّة سايكلوفوسفامايد:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الوبيورينول (يستعمل في علاج النقرس)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آزوثيوبرين (يستعمل للحد من نشاط الجهاز المناعي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كلورال هيدرات (يستعمل لعلاج الأرق)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيميتيدين (يستعمل لتقليل حموضة المعدة)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ديسولفرام (يستعمل في علاج إدمان الكحول)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جلسيرألدهايد (يستعمل لعلاج الثآليل)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات أنزيم البروتياز (تستعمل لعلاج الفيروسات)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أوندانسيترون (يستعمل لمنع الغثيان والقيء)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التي تزيد أنزيمات الكبد، مثل:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ريفامبيسين (يستعمل لعلاج الالتهابات البكتيرية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كاربامازيبين، الفينوباربيتال، الفينيتوين (تستعمل في علاج الصرع)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نبتة سان جون (عشبة تستعمل لعلاج الاكتئاب الخفيف)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكورتيزون (يستعمل لعلاج الالتهابات)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التي يمكن أن تزيد من التأثيرات الضارة على خلايا الدم والمناعة، مثل:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات ACE الإنزيم المحول للأنجيوتنسين (تستعمل لعلاج ارتفاع ضغط الدم)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ناتاليزوماب (يستعمل لعلاج مرض التصلب المتعدد)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; باكليتاكسيل (يستعمل لعلاج الأورام السرطانية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مدرات البول الثيازيد مثل هيدروكلوروثيازيد أو كلورتاليدون (تستعمل لعلاج ارتفاع ضغط الدم أو احتباس الماء)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيدوفودين (يستعمل لعلاج الفيروسات).</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كلوزابين (يستعمل لعلاج أعراض بعض الاضطرابات النفسية)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التي يمكن أن تزيد من التأثيرات الضارة على القلب، مثل:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انثراسايكلينز مثل بليوميسين، دوكسوروبيسين، إبيوروبيسين ، ميتوميسين (تستعمل لعلاج الأورام السرطانية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيتارابين، بينتوستاتين، تراستوزوماب (تستعمل لعلاج الأورام السرطانية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعرض للإشعاع في محيط منطقة الصدر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التي يمكن أن تزيد من التأثيرات الضارة على الرئة، مثل:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أميودارون (يستعمل في علاج عدم انتظام ضربات القلب)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هرمونات &nbsp;G-CSF، GM-CSF &nbsp;(تستعمل لزيادة تعداد خلايا الدم البيضاء بعد العلاج الكيميائي)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التي يمكن أن تزيد من التأثيرات الضارة على الكليتين، مثل:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمفوتريسين بي (تستعمل لعلاج الالتهابات الفطرية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إندوميثاسين (يستعمل لعلاج الألم والالتهاب)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية الأخرى التي يمكن أن تُؤثر أو تتأثر بـ سايكلوفوسفامايد، وتشمل ما يلي:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ايتانرسبت (يستعمل لعلاج التهاب المفاصل الروماتويدي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ميترونيدازول (يستعمل لعلاج الالتهابات البكتيرية أو الطفيلية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تاموكسيفين (يستعمل لعلاج أورام الثدي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بيبروبيون (يستعمل للمساعدة في وقف التدخين)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كومارينز مثل الوارفارين (يستعمل لسيولة الدم)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيكلوسبورين (يستعمل للحد من نشاط الجهاز المناعي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سكسينيل كولين (يستعمل لاسترخاء العضلات خلال العمليات الجراحية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الديجوكسين، &szlig;-acetyldigoxin &nbsp;(يستعمل لعلاج أمراض القلب)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اللقاحات</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فيراباميل (يستعمل لعلاج ارتفاع ضغط الدم، والذبحة الصدرية أو عدم انتظام ضربات القلب)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>سايكلوفوسفامايد مع الطعام والشراب</strong></p><p dir="RTL">تناول الكحول يمكن أن يزيد من الغثيان والقيء التي يسببها سايكلوفوسفامايد.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل، والرضاعة الطبيعية، ومنع الحمل</strong></p><p dir="RTL">من الضروري عدم الحمل أثناء العلاج بـ سايكلوفوسفامايد. لأنه يمكن أن يسبب الإجهاض أو يضر بصحة الجنين. أخبري الطبيب إذا كنتِ حامل، أو تعتقدي بأنكِ قد تكوني حامل أو أنك تحاولين الإنجاب.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبغي للرجال و النساء عدم محاولة إنجاب طفل أثناء و على الأقل لمدة 6 الى 12 شهراً بعد العلاج. يجب استخدام وسائل منع الحمل الفعّالة. إسأل طبيبك للحصول على المشورة.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سايكلوفوسفامايد يمكن أن يؤثر على القدرة على إنجاب الأطفال في المستقبل. تحدث مع الطبيب حول تجميد عينات الحيوانات المنوية أو البويضات قبل بدء العلاج.</p><p dir="RTL">لا يجب أن تقومي بالرضاعة الطبيعة أثناء العلاج بـ سايكلوفوسفامايد. إسألي الطبيب للحصول على المشورة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>القيادة واستخدام الآليات</strong></p><p dir="RTL">بعض الآثار الجانبية للعلاج بـ سايكلوفوسفامايد قد تؤثر على قدرتك على القيادة واستخدام الآلات بأمان. الطبيب من سيقرر إذا كان ذلك آمنا بالنسبة لك أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ماذا تفعل إن ذهبت إلى طبيب آخر غير طبيبك، أو ذهبت إلى مستشفى آخر</strong></p><p dir="RTL">إذا ذهبت الى أي طبيب غير طبيبك المعالج أو ذهبت إلى مستشفى غير المستشفى الذي تخضع فيه للعلاج بـ سايكلوفوسفامايد لأي سبب من الأسباب، أخبرهم بالأدوية التي تتناولها. لا تتناول أي أدوية أخرى ما لم يعرف الطبيب أنك تتناول علاج سايكلوفوسفامايد.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>تناول هذا الدواء</strong></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص سايكلوفوسفامايد تؤخذ عن طريق الفم. لا تمضغها.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أيضا دواء (يوروميتيكسان &quot;ميسنا&quot;)، طبيبك سوف يخبرك بمقدار الجرعة.</p><p dir="RTL">يجب أن تتناول الأقراص مع كمية كافية من السوائل ليسهل إبتلاعها.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عادة ما يعطى سايكلوفوسفامايد مع غيره من الأدوية المضادة للأورام السرطانية أو مع العلاج الإشعاعي.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الجرعة المعتادة</strong></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطبيب من سوف يقرر كم تحتاج من الدواء ومتى يجب عليك تناوله.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية سايكلوفوسفامايد التي سوف تحتاج إلى تناولها تعتمد على:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوع المرض</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حجم الجسم (بحساب الطول و الوزن)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصحة العامة للجسم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ما إذا كان يتم إعطاؤك أدوية أخرى مضادة للأورام او تخضع للعلاج الإشعاعي.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة المعتادة هي ما بين ١٠٠ ملغم (قرصين) و ٣٠٠ ملغم (٦ أقراص) في اليوم الواحد. يمكنك أخذ كل أقراص اليوم الواحد معاً، ولكن عليك أن تحاول أخذها في الوقت نفسه تقريباً كل يوم، ويفضل في الصباح. إذا كنت غير متأكد من كيفية تناول الأقراص، إسأل الطبيب أو الصيدلي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم أخذ سايكلوفوسفامايد عادة لعدة أيام بإستمرار كـ دورة علاج، ثم هناك فترة توقف (فترة لا يتم تناول أي أقراص) قبل الدورة المقبلة. في بعض الأحيان قد تحتاج إلى تناول عدد مختلف من الأقراص يوما بعد يوم، على سبيل المثال، ٣ أقراص في يوم&nbsp; و ٤ أقراص في اليوم التالي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الطبيب قد يحتاج إلى تغيير كمية الدواء الذي يتم إعطاءها لك و يراقبك عن كثب إذا:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك مشاكل في الكبد أو الكليتين</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت من كبار السن.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت أن تتناول سايكلوفوسفامايد</strong></p><p dir="RTL">إذا نسيت أن تتناول جرعة سايكلوفوسفامايد:</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان ذلك في نفس اليوم، يجب أخذ الجرعة حينما تتذكر. إذا كنت قد نسيت أن تتناول أقراص يومًا كاملًا، حينها يجب عليك التحدث مع الطبيب.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتناول أكثر من عدد الأقراص التي من المفترض تناولها في اليوم الواحد والمقررة لك من قبل الطبيب -&nbsp; لذلك لا تتناول جرعة يومين من الأقراص في يوم واحد من أجل &quot;اللحاق&quot;.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تناولت أكثر من الجرعة المقررة من سايكلوفوسفامايد</strong></p><p dir="RTL">&nbsp;في حالة الجرعة الزائدة، أو إذا كان طفل إبتلع أي من أقراص سايكلوفوسفامايد، تحدث إلى الطبيب على الفور أو إتصل بقسم الطوارئ في المستشفى القريب لديك فوراً. قد يكون هناك حاجة إلى التنويم في المستشفى لتلقي العلاجات الخاصة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، سايكلوفوسفامايد يمكن أن يسبب آثاراً جانبية، وإن لم يكن الجميع يحصل لهم تلك الآثار الجانبية. في بعض الأحيان يمكن أن تحدث آثار جانبية بعد انتهاء العلاج. الآثار الجانبية التالية قد تحدث مع إستعمال هذا الدواء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>أخبر الطبيب فوراً، وإذهب إلى المستشفى حالاً إذا لاحظت أي من الآثار الجانبية الخطيرة التالية</strong><strong>:</strong></p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط الحساسية ، وتكون علامات فرط الحساسية: ضيق في التنفس، صفير، طفح جلدي، حكة أو تورم في الوجه والشفتين (فرط الحساسية). الحساسية الشديدة يمكن أن تؤدي إلى صعوبة في التنفس أو صدمة، مع نتائج مهددة للحياة محتملة (صدمة الحساسية، رد فعل تحسسي شديد)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور كدمات دون إصابة، أو نزيف في اللثة. وهذا ربما قد يكون علامة على أن مستويات الصفائح الدموية في الدم منخفضة جدا</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إنخفاض في تعداد كريات الدم البيضاء، الطبيب سوف يتحقق من ذلك أثناء العلاج. هذا الإنخفاض لن يكون له أي علامات، ولكن سوف تكون أكثر احتمالا للتعرض للالتهابات والعدوى. إذا كنت تعتقد أن لديك إلتهاب وتعاني من (ارتفاع في درجة الحرارة، والشعور بالبرد والرعشة ، أو الشعور بالحرارة والتعرق، أو أي علامات للالتهاب مثل السعال، أو الشعور بوخز حاد أو ألم حارق في الحلق عند شرب الماء) قد تحتاج لمضادات حيوية لمكافحة الالتهاب لأن تعداد الدم أقل من المعتاد</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور دم في البول، أو الشعور بألم أثناء التبول، أو أن كمية البول تكون قليلة (التهاب المثانة النزفية، التبول الدموي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأمعاء الذي قد يؤدي إلى النزيف (التهاب الأمعاء النزفي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات (التشنجات)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات التي تهدد الحياة التي تسبب الطفح الجلدي والتقرحات والتهاب الحلق والحمى والتهاب الملتحمة وفصل طبقات الجلد (انحلال الجلد السمي &quot;توكسيك ابيديرمال نكرولوسيز&quot;، ومتلازمة ستيفنز جونسون). تورم، خدر، انتفاخات حمراء وتقشير الجلد على اليدين والقدمين (متلازمة بلمار-بلانتر اريثروديسثيسيا)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تهديد للحياة يتمثل في إنخفاض قابلية الكلى لإزالة السموم بشكل كاف من الدم (الفشل الكلوي). هذه التغييرات في أنسجة الكلى يمكن أن تمنعها من العمل بشكل صحيح، وحدوث الفشل الكلوي (نخرالأنابيب الكلوية، اضطراب الأنابيب الكلوية)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الالتهاب الرئوي. وعلامات ذلك يمكن ان تكون بالشعور بألم في الصدر عند التنفس أو السعال، تشوش، سعال، ارتفاع درجة الحرارة، التعرق والرعشة، الشعور بالتعب، صعوبة في التنفس، غثيان، قيء أو إسهال</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إلتهاب وعدوى شديدة تنتشر في الدم مما قد يؤدي إلى انخفاض خطير في ضغط الدم مع احتمالية الوفاة (الإنتان، الصدمة)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آثار على الدماغ (اعتلال الدماغ) ، وعلامات هذا يمكن أن يكون اضطرابات في التفكير أو التركيز، قلة التركيز، والتغيرات في الشخصية، والتعب، والتشنجات، ووخز العضلات، وارتعاش</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة ما يسمى &quot;اعتلال بيضاء الدماغ&quot; (اليكو انسيفالوباثي)، الذي يمكن أن يسبب تورم الدماغ، والصداع، والارتباك، وتشنجات وفقدان الابصار</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبة القلبية (احتشاء عضلة القلب)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض قدرة القلب على ضخ ما يكفي من الدم في جميع أنحاء الجسم والتي قد تكون مهددة للحياة (صدمة قلبية)، وفشل القلب أو السكتة القلبية</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في قدرة الرئتين على نقل الأكسجين إلى الدم (فشل الجهاز التنفسي)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم المواد السامة في الجسم بسبب فشل الكبد. مما قد يؤثر على خلايا المخ و يؤدي للإضطراب، وانخفاض الوعي أو الغيبوبة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر الطبيب فوراً إذا لاحظت أي من الآثار الجانبية الخطيرة التالية:</strong></p><ul><li dir="RTL">متلازمة يوريمي الدم الانحلالي - وهي حالة غير طبيعية مما تسبب في تكسر خلايا الدم الحمراء، وانخفاض عدد الصفائح الدموية في الدم وحدوث فشل كلوي</li><li dir="RTL">أورام الدم (اللوكيميا)</li><li dir="RTL">أورام نخاع العظم (مايلوديسبلاستك سيندروم)</li><li dir="RTL">إنتفاخ و تورم في الدماغ بسبب وجود كمية كبيرة من الماء في الدم (التسمم المائي). وعلامات هذا يمكن أن يكون الصداع، وتغييرات في الشخصية أو السلوك، والارتباك، والنعاس</li><li dir="RTL">تجلط الدم، وعادة في الساق، مما يسبب تورم الألم أو الاحمرار (التجلط الوريدي)</li><li dir="RTL">نقص الصوديوم في الدم ، والذي يمكن أن يسبب التعب والاضطراب، وارتعاش العضلات، وحدوث نوبات تشنج وحالات فقدان الوعي</li><li dir="RTL">الشعور بعدم الراحة في البطن وآلام الظهر، وهذا قد يكون ناجما عن التهاب البنكرياس الحاد</li><li dir="RTL">ارتفاع مستويات السكر في الدم الذي يمكن أن يسبب العطش، والتعب والإنفعال</li><li dir="RTL">انخفاض مستويات السكر في الدم الذي يمكن أن يسبب الاضطراب والتعرق</li><li dir="RTL">تأثيرات على الحبل الشوكي (مايلوباثي)، والتي يمكن أن تسبب خدر، وضعف وتنميل في اليدين، وفقدان المهارات الحركية</li><li dir="RTL">إعتلال عضلة القلب (كارديو مايلوباثي)؛ التهاب أنسجة القلب أو ما حوله ( إلتهاب عضلة القلب أو إلتهاب التامور)؛ تراكم السوائل في كيس حول القلب (الإرتشاح التاموري). زيادة الضغط من هذه السوائل يمكن أن يوقف إمتلاء القلب بالشكل الصحيح (كاردياك تامبوناد)؛ خلل في مؤشر تخطيط القلب ويسمى (إي سي جي كيو تي برولونجد) &ndash; وهذ يعتبر من أسباب عدم انتظام نبضات القلب</li><li dir="RTL">تغيرات في نبضات القلب (عدم انتظام نبضات القلب) والتي قد تكون ملحوظة (خفقان):</li></ul><p dir="RTL">- عدم انتظام نبضات القلب (الرجفان)</p><p dir="RTL">- سرعة نبضات القلب ، والتي قد تكون مهددة للحياة (سرعة نبضات القلب البطيني)</p><p dir="RTL">- بطء نبضات القلب</p><ul><li dir="RTL">تجلط الدم في الرئتين والذي يسبب ألم في الصدر وضيق في التنفس (الانسداد الرئوي)</li><li dir="RTL">تقرح في الرئتين والذي يسبب ضيق في التنفس</li><li dir="RTL">الحالات المسببة للالتهابات في الرئتين الذي يمكن أن يسبب ضيق التنفس والسعال وإرتفاع درجة الحرارة أو تقرح الرئتين (التهاب رئوي، متلازمة الضائقة التنفسية الحادة والتهاب القصيبات الهوائية، والالتهاب الرئوي المتكرر، والتهاب وحساسية الحويصلات الهوائي)</li><li dir="RTL">تجمع السوائل في الرئتين أو حولها</li><li dir="RTL">إرتفاع ضغط الدم في الرئتين الذي يمكن أن يسبب ضيق في التنفس، والتعب، والسعال، والذبحة الصدرية، والإغماء، والإستسقاء المحيطي</li><li dir="RTL">انهيار العضلات غير طبيعي والتي يمكن أن تؤدي إلى مشاكل في الكلى (ربدوميوليسيس)</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأورام آثار جانبية أخرى محتملة، مدرجة حسب تمرر حدوثها، والتي قد تكون:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة جداً</strong>: يمكن أن تُصيب أكثر من ١ لكل ١٠ أشخاص</p><ul><li dir="RTL">انخفاض في كفاءة الجهاز المناعي.</li></ul><ul><li dir="RTL">تساقط الشعر (الصلع)</li></ul><ul><li dir="RTL">ألم وصعوبة في التبول (التهاب المثانة)</li></ul><ul><li dir="RTL">الشحوب، والسبات العميق، والتعب قد يكون علامة على انخفاض خلايا الدم الحمراء (فقر الدم). عادة، لا يلزم العلاج، والجسم سوف يعوض خلايا الدم الحمراء في نهاية المطاف. قد تحتاج إلى نقل دم إذا كان فقر الدم شديدا</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>شائعة</strong>: يمكن أن تُصيب لغاية ١ لكل ١٠ أشخاص</p><ul><li dir="RTL">زيادة مخاطر الإصابة بالإلتهابات البكتيرية، والفطرية، والفيروسية، أو الطفيلية بسبب تأثير سايكلوفوسفامايد على الجهاز المناعي</li><li dir="RTL">إعادة تنشيط الالتهابات التي كانت لديك من قبل (الالتهابات الكامنة)</li><li dir="RTL">زيادة مستويات بعض الإنزيمات التي ينتجها الكبد. الطبيب سوف يجري بعض التحاليل للكشف عن مستويات هذه الإنزيمات</li><li dir="RTL">التهاب المثانة والذي يسبب ألم، ونزيف دم في البول. ويقلل كمية البول ( التهاب المثانة النزفي)</li><li dir="RTL">التهاب بطانات تجاويف الجسم (التهاب الغشاء المخاطي)</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير شائعة</strong>: يمكن أن تُصيب لغاية ١ لكل ١٠٠ شخص</p><ul><li dir="RTL">فقدان الشهية</li><li dir="RTL">احمرار الجلد، والتي قد تكون مصحوبة بالشعور بالسخونة أو التعرق</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة</strong>: يمكن أن تُصيب لغاية ١ لكل ١٠٠٠ شخص</p><ul><li dir="RTL">الأورام الثانوية في أجزاء متعددة من الجسم، غالبا في منطقة المثانة</li><li dir="RTL">الجفاف</li><li dir="RTL">الدوار</li><li dir="RTL">عدم وضوح الرؤية، وضعف أو فقدان الإبصار</li><li dir="RTL">تغيرات في لون الأظافر والجلد</li><li dir="RTL">التهاب الجلد الذي قد يسبب الطفح الجلدي، البثور، والحكة، والقروح، والندب المتقيحة</li><li dir="RTL">إنقطاع الدورة الشهرية (انقطاع الطمث)</li><li dir="RTL">ألم في الصدر</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة جداً</strong>: يمكن أن تُصيب لغاية ١ لكل ١٠,٠٠٠ شخص</p><ul><li dir="RTL">زيادة في إفراز الهرمون المضاد لإدرار البول من الغدة النخامية. وهذا يؤثر على الكليتين مما يسبب في انخفاض مستويات الصوديوم في الدم (هايبرناتريميا) وإحتباس الماء في الجسم</li><li dir="RTL">تجمع السوائل في الجسم (احتباس الماء)، حيث يتم الشعور به بوجود سوائل تحت الجلد أو تورم في الأطراف</li><li dir="RTL">الشعور بالاعياء (الغثيان والقيء)</li><li dir="RTL">الإمساك أو الإسهال</li><li dir="RTL">تقرحات في بطانة الجهاز الهضمي&nbsp;</li><li dir="RTL">التهاب تجويف الفم بما في ذلك قرحة الفم</li><li dir="RTL">حالة التشوش والإرتباك</li><li dir="RTL">تقرحات أو ندبات (تليف) في المثانة</li><li dir="RTL">التهاب ملتحمة العين</li><li dir="RTL">وذمة العين (تورم)</li></ul><p dir="RTL"><strong>غير معروف</strong>: لا يمكن تقدير تكرار حدوث الآثار الجانبية التالية من البيانات المتاحة</p><ul><li dir="RTL">تغييرات في التمثيل الغذائي الناجمة عن تحلل الخلايا السرطانية (متلازمة تحلل الورم)</li></ul><ul><li dir="RTL">الإلتهاب المعوي الذي قد يؤدي إلى النزيف (التهاب الأمعاء، التهاب الأعور، الإلتهاب المعوي القولوني النزفي)</li><li dir="RTL">نزيف في المعدة أو الأمعاء (نزف معوي)</li><li dir="RTL">الالتهاب الذي يسبب آلام في البطن أو إسهال (التهاب القولون)</li><li dir="RTL">تورم في الغدد اللعابية (التهاب الغدة النكافية)</li><li dir="RTL">اضطراب في الأعصاب الذي يمكن أن يسبب ضعف، وتنميل أو خدر (بيريفرال نيروباثي). هذا يمكن أن يكون في أكثر من مجموعة من الأعصاب (بولي نيروباثي)</li><li dir="RTL">الآلام الأعصاب، والذي يمكن أن الشعور به مثل الإحساس المؤلم أو حرقان</li><li dir="RTL">تنميل أو خدر، وغالبا في اليدين أو القدمين</li><li dir="RTL">رعاش</li><li dir="RTL">تغيرات في حاسة اللمس (ضعف الإحساس أو فقدان الإحساس)</li><li dir="RTL">تغيرات في حاسة التذوق (ضعف في التذوق أو فقدان التذوق)</li><li dir="RTL">تغيرات في حاسة الشم</li><li dir="RTL">زيادة تكون الدموع</li><li dir="RTL">الصمم أو ضعف السمع</li><li dir="RTL">طنين في الأذنين</li><li dir="RTL">التهاب الأوعية الدموية</li><li dir="RTL">انخفاض تدفق الدم الى اليدين والقدمين (نقص التروية المحيطية). قد يسبب هذا الألم والضعف والخدر، وتقرح الجلد، والتغيرات في لون البشرة أو درجات الحرارة</li><li dir="RTL">صعوبة في التنفس أو الصفير</li><li dir="RTL">ضيق في التنفس</li><li dir="RTL">انخفاض مستويات الأكسجين في الجسم</li><li dir="RTL">السعال</li><li dir="RTL">انسداد أو سيلان الأنف</li><li dir="RTL">الألم في الجزء الخلفي من الحلق</li><li dir="RTL">تضخم الكبد</li><li dir="RTL">اصفرار الجلد أو بياض العينين (اليرقان)</li><li dir="RTL">انسداد أوردة صغيرة في الكبد ، الذي يمكن أن يسبب زيادة الوزن، وتضخم الكبد والألم واليرقان</li><li dir="RTL">حالات تسبب التهاب الكبد الذي يمكن أن يسبب اليرقان، وفقدان الوزن والشعور بالضيق (التهاب الكبد)</li><li dir="RTL">اضطراب تشكل الصفراء في الكبد الذي يمكن أن يسبب الحكة، واليرقان، شحوب لون البراز وتغير لون البول ليصبح داكن</li><li dir="RTL">تراكم السوائل في البطن مما يسبب إنتفاخ في البطن وضيق في التنفس (استسقاء)</li><li dir="RTL">إحمرار و طفح و حكة (الشري)</li><li dir="RTL">احمرار وظهور تقرحات في الجلد تظهر لأشهر أو لسنوات بعد العلاج</li><li dir="RTL">حكة، طفح جلدي أحمر التي يمكن أن تتطور في لقروح</li><li dir="RTL">التعرق المفرط</li><li dir="RTL">تورم في الوجه</li><li dir="RTL">حكة في الجلد</li><li dir="RTL">إعتلال شديد يسبب سماكة في الجلد والنسيج الضام في الأعضاء الداخلية (تصلب الجلد)</li></ul><ul><li dir="RTL">تشنجات العضلات</li><li dir="RTL">ألآم العضلات والمفاصل</li><li dir="RTL">تضرر الكليتين من المواد السامة في الدم ( تسمم الكلى)</li><li dir="RTL">وجود سكر في البول (السكري الكلوي)</li></ul><ul><li dir="RTL">التهاب مجرى البول الذي يسبب الألم والنزيف (التهاب الحالب النزفي)</li><li dir="RTL">موت الخلايا والأنسجة (نكروزيس)</li><li dir="RTL">تقلص حجم المثانة</li><li dir="RTL">تغيرات في خلايا بطانة المثانة</li><li dir="RTL">زيادة مستويات الكرياتنيين أو اليوريا نيتروجين في الدم. سوف يجري الطبيب فحوصات الدم اللازمة لمراقبة ذلك</li><li dir="RTL">الإجهاض</li><li dir="RTL">العقم. إنتاج الحيوانات المنوية في الرجال وإنتاج البويضات في النساء قد يقل أو يقف. وفي بعض الحالات يمكن أن يكون ذلك بشكل دائم</li><li dir="RTL">تناقص تكرار فترات الدورة الشهرية</li><li dir="RTL">تقلص في حجم الخصيتين</li><li dir="RTL">إنخفاض مستوى هرمون أوستروجين في الدم</li><li dir="RTL">زيادة مستوى هرمون جونادوتروفين في الدم</li><li dir="RTL">قد یؤدي الاستخدام في المرضی الصغار في السن إلی بعض حالات القصور في الخصوبة في المستقبل</li><li dir="RTL">انخفاض في نمو أو تشوه أو وفاة الجنين أثناء وجوده في الرحم</li><li dir="RTL">آثار سامة على الجنين مثل كبت نخاع العظم والتهاب المعدة والأمعاء</li><li dir="RTL">فشل مهدد للحياة لأجهزة متعددة في الجسم مثل القلب والرئتين والكلى والكبد (انظر الآثار في القسم 4)</li><li dir="RTL">تضرر او تلف جسدي عام</li><li dir="RTL">أعراض تشبه الأنفلونزا مثل الصداع والحمى وقشعريرة وآلام المفاصل والعضلات، والضعف، والتعب</li><li dir="RTL">إنتفاخ وتورم في الجسم</li><li dir="RTL">رد فعل في موقع الحقن</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الآثار الجانبية</strong><strong>:</strong></p><p dir="RTL">إذا حدث لك أي آثار جانبية، تحدث مع طبيبك أو الممرضة أو الصيدلي. وهذا يشمل أي آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضا الإبلاغ عن الآثار الجانبية مباشرة (انظر التفاصيل أدناه). إبلاغك عن الآثار الجانبية؛ يساعدك في الحصول على المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية</strong><strong>:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td style="vertical-align:top"><ul><li dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية</li></ul><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;مركز اتصال الهيئة العامة للغذاء والدواء السعودية: 19999</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;موقع الويب: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى</strong><strong>:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُرجى الاتصال بالهيئة المختصة ذات الصلة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حافظ على هذا الدواء بيعداً عن أعين وأيدي الأطفال.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم سايكلوفوسفامايد بعد تاريخ انتهاء الصلاحية المدون على العبوة بعد إختصار (EXP). يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إحفظ الدواء في درجة حرارة أقل من ٢٥ درجة مئوية. إحفظ الددواء في العبوة الأصلية.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا ينبغي التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. إذا تبقى لديك كمية من أي دواء، أعده إلى الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>على ماذا يحتوي سايكلوفوسفامايد</strong></p><p dir="RTL">المادة الفعالة هي ستيكلوفوسفامايد وكل قرص يحتوي على 50 ملغم.</p><p dir="RTL">المكونات الأخرى هي: نشا الذرة، لاكتوز مونوهيدرات، كالسيوم هيدروجين فوسفات، التلك، مغنيسيوم ستيرات، الجيلاتين، الجلسرول، السكروز، ثاني أكسيد التيتانيوم (E171)، كربونات الكالسيوم، ماكروغول، السيليكا الغروية اللامائية، البوفيدون، كارملوز الصوديوم، بوليسوربات 20، مونتان جلايكول واكس.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو سايكلوفوسفامايد و ماهي محتويات العبوة</strong></p><p dir="RTL">أقراص سايكلوفوسفامايد هي أقراص بيضاء، مستديرة، مغلفة مع لب أبيض. تحتوي العبوة على٥٠ قرص موزعة على ٥ أشرطة؛ كل شريط يحتوي على 10 أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">حامل ترخيص التسويق والمُصنع</p><p dir="RTL">حامل ترخيص التسويق:</p><p dir="RTL"><strong>Baxter Oncology GmbH</strong></p><p dir="RTL">Kantstrasse&nbsp;2</p><p dir="RTL">33790&nbsp;Halle/Westfalen</p><p dir="RTL">Germany</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم تصنيعه بواسطة:</p><p dir="RTL">Prasfarma S.L., Spain</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تحديث هذه النشرة في يناير 2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Endoxan Tablets 50 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains cyclophosphamide monohydrate equivalent to 50 mg anhydrous cyclophosphamide.

Throughout this Summary of Product Characteristics, Endoxan Tablets 50 mg will be called Cyclophosphamide.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Coated Tablet.
White round biconvex sugar coated tablets with a white core.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide is a cytotoxic drug for the treatment of malignant disease in adults and children. As a single agent, it has successfully produced an objective remission in a wide range of malignant conditions. Cyclophosphamide is also frequently used in combination with other cytotoxic drugs, radiotherapy or surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide Tablets are for oral use.</p><p>&nbsp;</p><p>Cyclophosphamide should only be used by clinicians experienced in the use of cancer chemotherapy. Cyclophosphamide should only be administered where there are facilities for regular monitoring of clinical, biochemical and haematological parameters before, during, and after administration and under the direction of a specialist oncology service.</p><p>&nbsp;</p><p>Posology</p><p><strong>&nbsp;</strong></p><p>Dosage must be individualized. Doses and duration of treatment and/or treatment intervals depend on the therapeutic indication, the scheme of a combination therapy, the patient&rsquo;s general state of health and organ function, and the results of laboratory monitoring (in particular, blood cell monitoring).</p><p>&nbsp;</p><p>The dosage regimen used for most indications is 100 &ndash; 300 mg daily as a single or divided dose.</p><p>&nbsp;</p><p>This treatment should be continued until a clear remission or improvement is seen or be interrupted when the extent of leucopenia becomes unacceptable.</p><p>&nbsp;</p><p>In combination with other cytostatics of similar toxicity, a dose reduction or extension of the therapy-free intervals may be necessary.</p><p>&nbsp;</p><p>Activation of cyclophosphamide requires hepatic metabolism; therefore, oral and intravenous administrations are preferred.</p><p>&nbsp;</p><p>Use of hematopoiesis stimulating agents (colony-stimulating factors and erythropoiesis stimulating agents) may be considered to reduce the risk of myelosuppressive complications and/or help facilitate the delivery of the intended dosing.</p><p>&nbsp;</p><p>During or immediately after the administration, adequate amounts of fluid should be ingested or infused to force diuresis in order to reduce the risk of urinary tract toxicity. Therefore, cyclophosphamide should be administered in the morning. See Section 4.4.</p><p>&nbsp;</p><p><u>Patients with Hepatic Impairment</u></p><p>&nbsp;</p><p>Severe hepatic impairment may be associated with decreased activation of cyclophosphamide. This may alter the effectiveness of cyclophosphamide treatment and should be considered when selecting the dose and interpreting response to the dose selected.</p><p>&nbsp;</p><p><u>Patients with Renal Impairment</u></p><p>&nbsp;</p><p>In patients with renal impairment, particularly in patients with severe renal impairment, decreased renal excretion may result in increased plasma levels</p><p>of cyclophosphamide and its metabolites. This may result in increased toxicity and should be considered when determining the dosage in such patients.</p><p>&nbsp;</p><p>Cyclophosphamide and its metabolites are dialyzable, although there may be differences in clearance depending upon the dialysis system being used. In patients requiring dialysis, use of a consistent interval between cyclophosphamide administration and dialysis should be considered. See Section 4.4.</p><p>&nbsp;</p><p><u>Elderly</u></p><p>&nbsp;</p><p>In elderly patients, monitoring for toxicities and the need for dose adjustment should reflect the higher frequency of decreased hepatic, renal, cardiac, or other organ function, and concomitant diseases or other drug therapy in this population.</p><p>&nbsp;</p><p><u>Children</u></p><p>&nbsp;</p><p>No specific information.&nbsp; Children have received Cyclophosphamide. No adverse reactions specific to this group have been reported.</p><p>&nbsp;</p><p><u>Method of Administration</u></p><p>&nbsp;</p><p>Cyclophosphamide Tablets should be swallowed with sufficient fluid without chewing. The tablets are coated and should not be divided before use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cyclophosphamide is contra-indicated in patients with:

•	hypersensitivity to cyclophosphamide or to any of its metabolites.
•	acute infections,
•	bone-marrow aplasia,
•	urinary tract infection
•	acute urothelial toxicity from cytotoxic chemotherapy or radiation therapy
•	Urinary outflow obstruction.

Cyclophosphamide should not be used in the management of non-malignant disease, except for immunosuppression in life-threatening situations.

Cyclophosphamide is contra-indicated during pregnancy. See section 4.4 and 4.6.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>WARNINGS</p><p><strong>&nbsp;</strong></p><p><u>Anaphylactic Reactions, Cross-sensitivity with Other Alkylating Agents</u></p><p>&nbsp;</p><p>Anaphylactic reactions including those with fatal outcomes have been reported in association with cyclophosphamide.</p><p>&nbsp;</p><p>Possible cross-sensitivity with other alkylating agents has been reported. <u>Myelosuppression, Immunosuppression, Infections</u></p><p>Treatment with cyclophosphamide may cause myelosuppression and significant suppression of immune responses.</p><p>&nbsp;</p><p>Cyclophosphamide-induced myelosuppression can cause leukopenia, neutropenia, thrombocytopenia (associated with a higher risk of bleeding events), and anaemia.</p><p>&nbsp;</p><p>Severe immunosuppression has lead to serious, sometimes fatal, infections. Sepsis and septic shock have also been reported. Infections reported with cyclophosphamide include pneumonias, as well as other bacterial, fungal, viral, protozoal, and parasitic infections.</p><p>&nbsp;</p><p>Latent infections can be reactivated. Reactivation has been reported for various bacterial, fungal, viral, protozoal, and parasitic infections.</p><p>&nbsp;</p><p>Infections must be treated appropriately.</p><p>&nbsp;</p><p>Antimicrobial prophylaxis may be indicated in certain cases of neutropenia at the discretion of the managing physician.</p><p>&nbsp;</p><p>In case of neutropenic fever, antibiotics and/or antimycotics must be given.</p><p>&nbsp;</p><p>&nbsp;</p><p>Cyclophosphamide should be used with caution, if at all, in patients with severe impairment of bone marrow function and in patients with severe immunosuppression.</p><p>&nbsp;</p><p>Unless essential, cyclophosphamide should not be administered to patients with a leukocyte count below 2500 cells/microlitre (cells/ mm3 and/or a platelet count below 50,000 cells/microlitre (cells/mm3).</p><p>&nbsp;</p><p>Cyclophosphamide treatment may not be indicated, or should be interrupted, or the dose reduced, in patients who have or who develop a serious infection.</p><p>&nbsp;</p><p>In principle, the fall in the peripheral blood cell and thrombocyte count and the time taken to recover may increase with increasing doses of cyclophosphamide.</p><p>&nbsp;</p><p>The nadirs of the reduction in leukocyte count and thrombocyte count are usually reached in weeks 1 and 2 of treatment. The bone marrow recovers relatively quickly, and the levels of peripheral blood cell counts normalize, as a rule, after approximately 20 days.</p><p>&nbsp;</p><p>Severe myelosuppression must be expected particularly in patients pretreated with and/or receiving concomitant chemotherapy and/or radiation therapy.</p><p>&nbsp;</p><p>Close haematological monitoring is required for all patients during treatment. <u>Urinary Tract and Renal Toxicity</u></p><p>Hemorrhagic cystitis, pyelitis, ureteritis, and haematuria have been reported with cyclophosphamide therapy. Bladder ulceration/necrosis, fibrosis/contracture and secondary cancer may develop.</p><p>&nbsp;</p><p>Urotoxicity may mandate interruption of treatment.</p><p>&nbsp;</p><p>Cystectomy may become necessary due to fibrosis, bleeding, or secondary malignancy.</p><p>&nbsp;</p><p>Cases of urotoxicity with fatal outcomes have been reported.</p><p>&nbsp;</p><p>Urotoxicity can occur with short-term and long-term use of cyclophosphamide. Hemorrhagic cystitis after single doses of cyclophosphamide has been reported.</p><p>&nbsp;</p><p>Past or concomitant radiation or busulfan treatment may increase the risk for cyclophosphamide-induced hemorrhagic cystitis.</p><p>&nbsp;</p><p>Cystitis is, in general, initially abacterial. Secondary bacterial colonization may follow.</p><p>&nbsp;</p><p>Before starting treatment, it is necessary to exclude or correct any urinary tract obstructions. See Section 4.3.</p><p>&nbsp;</p><p>Urinary sediment should be checked regularly for the presence of erythrocytes and other signs of uro/nephrotoxicity.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Cyclophosphamide should be used with caution, if at all, in patients with active urinary tract infections.</p><p>&nbsp;</p><p>Adequate treatment with mesna and/or strong hydration to force dieresis can markedly reduce the frequency and severity of bladder toxicity. It is important to ensure that patients empty the bladder at regular intervals.</p><p>&nbsp;</p><p>Hematuria usually resolves in a few days after cyclophosphamide treatment is stopped, but it may persist.</p><p>&nbsp;</p><p>It is usually necessary to discontinue cyclophosphamide therapy in instances of severe hemorrhagic cystitis.</p><p>&nbsp;</p><p>Cyclophosphamide has also been associated with nephrotoxicity, including renal tubular necrosis.</p><p>&nbsp;</p><p>Hyponatremia associated with increased total body water, acute water intoxication, and a syndrome resembling SIADH (syndrome of inappropriate secretion of antidiuretic hormone) have been reported in association with cyclophosphamide administration. Fatal outcomes have been reported.</p><p>&nbsp;</p><p><u>Cardiotoxicity, Use in Patients with Cardiac Disease</u></p><p>&nbsp;</p><p>Myocarditis and myopericarditis, which may be accompanied by significant pericardial effusion and cardiac tamponade, have been reported with cyclophosphamide therapy and have led to severe, sometimes fatal congestive heart failure.</p><p>&nbsp;</p><p>Histopathologic examination has primarily shown hemorrhagic myocarditis. Haemopericardium has occurred secondary to hemorrhagic myocarditis and myocardial necrosis.</p><p>&nbsp;</p><p>Acute cardiac toxicity has been reported with a single dose of less than 2mg/kg cyclophosphamide.</p><p>&nbsp;</p><p>Following exposure to treatment regimens that included cyclophosphamide, supraventricular arrhythmias (including atrial fibrillation and flutter) as well as ventricular arrhythmias (including severe QT prolongation associated with ventricular tachyarrhythmia) have been reported in patients with and without other signs of cardiotoxicity.</p><p>&nbsp;</p><p>The risk of cyclophosphamide cardiotoxicity may be increased for example, following high doses of cyclophosphamide, in patients with advanced age, and in patients with previous radiation treatment of the cardiac region and/or previous or concomitant treatment with other cardiotoxic agents. See Section 4.5.</p><p>&nbsp;</p><p>Particular caution is necessary in patients with risk factors for cardiotoxicity and in patients with pre-existing cardiac disease.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Pulmonary Toxicity</u></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Pneumonitis and pulmonary fibrosis have been reported during and following treatment with cyclophosphamide. Pulmonary veno-occlusive disease and other forms of pulmonary toxicity have also been reported.</p><p>&nbsp;</p><p>Pulmonary toxicity leading to respiratory failure has been reported.</p><p>&nbsp;</p><p>While the incidence of cyclophosphamide-associated pulmonary toxicity is low, prognosis for affected patients is poor.</p><p>&nbsp;</p><p>Late onset of pneumonitis (greater than 6 months after start of cyclophosphamide) appears to be associated with a particularly high mortality. Pneumonitis may develop even years after treatment with cyclophosphamide.</p><p>&nbsp;</p><p>Acute pulmonary toxicity has been reported after a single cyclophosphamide dose.</p><p>&nbsp;</p><p><u>Secondary Malignancies</u></p><p>&nbsp;</p><p>As with all cytotoxic therapy, treatment with cyclophosphamide involves the risk of secondary tumours and their precursors as late sequelae.</p><p>&nbsp;</p><p>The risk of urinary tract cancer as well as the risk of myelodysplastic alterations, partly progressing to acute leukemias, is increased. Other malignancies reported after use of cyclophosphamide or regimens with cyclophosphamide include lymphoma, thyroid cancer, and sarcomas.</p><p>&nbsp;</p><p>In some cases, the second malignancy developed several years after cyclophosphamide treatment had been discontinued. Malignancy has also been reported after <em>in utero </em>exposure.</p><p>&nbsp;</p><p><u>Veno-occlusive Liver Disease</u></p><p>&nbsp;</p><p>Veno-occlusive liver disease (VOLD) has been reported in patients receiving cyclophosphamide.</p><p>&nbsp;</p><p>A cytoreductive regimen in preparation for bone marrow transplantation that consists of cyclophosphamide in combination with whole-body irradiation, busulfan, or other agents has been identified (see Section 4.5) as a major risk factor for the development of VOLD. After cytoreductive therapy, the clinical syndrome typically develops 1 to 2 weeks after transplantation and is characterized by sudden weight gain, painful hepatomegaly, ascites, and hyperbilirubinemia/jaundice.</p><p>&nbsp;</p><p>However, VOLD has also been reported to develop gradually in patients receiving long-term low-dose immunosuppressive doses of cyclophosphamide.</p><p>&nbsp;</p><p>As a complication of VOLD, hepatorenal syndrome and multiorgan failure may develop. Fatal outcome of cyclophosphamide-associated VOLD has been reported.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Risk factors predisposing a patient to the development of VOLD with high- dose cytoreductive therapy include:</p><p>&nbsp;</p><p>&ndash;&nbsp; preexisting disturbances of hepatic function,</p><p>&ndash;&nbsp; previous radiation therapy of the abdomen, and a</p><p>&ndash;&nbsp; low performance score.</p><p>&nbsp;</p><p><u>Genotoxicity</u></p><p>&nbsp;</p><p>Cyclophosphamide is genotoxic and mutagenic, both in somatic and in male and female germ cells. Therefore, women should not become pregnant and men should not father a child during therapy with cyclophosphamide.</p><p>&nbsp;</p><p>Both women and men should wait at least 6 to 12 months after stopping Cyclophosphamide before attempting to conceive or father a child.</p><p>&nbsp;</p><p>Animal data indicate that exposure of oocytes during follicular development may result in a decreased rate of implantations and viable pregnancies, and in an increased risk of malformations. This effect should be considered in case of intended fertilization or pregnancy after discontinuation of cyclophosphamide therapy. The exact duration of follicular development in humans is not known, but may be longer than 12 months.</p><p>&nbsp;</p><p>Sexually active women and men should use effective methods of contraception during these periods of time.</p><p>&nbsp;</p><p>Fertility, see section 4.6. <u>Impairment of Wound Healing</u></p><p>Cyclophosphamide may interfere with normal wound healing.</p><p>&nbsp;</p><p>PRECAUTIONS</p><p><strong>&nbsp;</strong></p><p><u>Alopecia</u></p><p>&nbsp;</p><p>Alopecia has been reported and may occur more commonly with increasing doses.</p><p>&nbsp;</p><p>Alopecia may progress to baldness.</p><p>&nbsp;</p><p>The hair can be expected to grow back after treatment with the drug or even during continued drug treatment, though it may be different in texture or colour.</p><p>&nbsp;</p><p><u>Nausea and Vomiting</u></p><p>&nbsp;</p><p>Administration of cyclophosphamide may cause nausea and vomiting.</p><p>&nbsp;</p><p>Current guidelines on the use of antiemetics for prevention and amelioration of nausea and vomiting should be considered.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Alcohol consumption may increase cyclophosphamide-induced vomiting and nausea.</p><p>&nbsp;</p><p><u>Stomatitis</u></p><p>&nbsp;</p><p>Administration of cyclophosphamide may cause stomatitis (oral mucositis).</p><p>&nbsp;</p><p>Current guidelines on measures for prevention and amelioration of stomatitis should be considered.</p><p>&nbsp;</p><p><u>Paravenous Administration</u></p><p>&nbsp;</p><p>The cytostatic effect of cyclophosphamide occurs after its activation, which takes place mainly in the liver. Therefore, the risk of tissue injury from accidental paravenous administration is low.</p><p>&nbsp;</p><p>In case of accidental paravenous administration of cyclophosphamide, the infusion should be stopped immediately, the extravascular cyclophosphamide solution should be aspirated with the cannula in place, and other measures should be instituted as appropriate.</p><p>&nbsp;</p><p><u>Use in Patients with Renal Impairment</u></p><p>&nbsp;</p><p>In patients with renal impairment, particularly in patients with severe renal impairment, decreased renal excretion may result in increased plasma levels</p><p>of cyclophosphamide and its metabolites. This may result in increased toxicity and should be considered when determining the dosage in such patients. See Section 4.2.</p><p>&nbsp;</p><p><u>Use in Patients with Hepatic Impairment</u></p><p>&nbsp;</p><p>Severe hepatic impairment may be associated with decreased activation of cyclophosphamide. This may alter the effectiveness of cyclophosphamide treatment and should be considered when selecting the dose and interpreting response to the dose selected.</p><p>&nbsp;</p><p><u>Use in Adrenalectomized Patients</u></p><p>&nbsp;</p><p>Patients with adrenal insufficiency may require an increase in corticoid substitution dose when exposed to stress from toxicity due to cytostatics, including cyclophosphamide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Planned coadministration or sequential administration of other substances or treatments that could increase the likelihood or severity of toxic effects (by means of pharmacodynamic or pharmacokinetic interactions) requires careful individual assessment of the expected benefit and the risks.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Patients receiving such combinations must be monitored closely for signs of toxicity to permit timely intervention. Patients being treated with cyclophosphamide and agents that reduce its activation should be monitored for a potential reduction of therapeutic effectiveness and the need for dose adjustment.</p><p>&nbsp;</p><p><u>Interactions Affecting the Pharmacokinetics of Cyclophosphamide and its</u> <u>Metabolites</u></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced activation of cyclophosphamide may alter the effectiveness of cyclophosphamide treatment. Substances that delay activation of cyclophosphamide include:</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp; Aprepitant</p><p>&ndash;&nbsp;&nbsp;&nbsp; Bupropion</p><p>&ndash;&nbsp;&nbsp;&nbsp; Busulfan: Cyclophosphamide clearance has been reported to be reduced and half-life prolonged in patients who receive high-dose cyclophosphamide less than 24 hours after high-dose busulfan.</p><p>&ndash;&nbsp;&nbsp;&nbsp; Ciprofloxacin: When given prior to the treatment with cyclophosphamide (used for conditioning prior to bone marrow transplantation), ciprofloxacin has been reported to result in a relapse of the underlying disease.</p><p>&ndash;&nbsp;&nbsp;&nbsp; Chloramphenicol</p><p>&ndash;&nbsp;&nbsp;&nbsp; Fluconazole</p><p>&ndash;&nbsp;&nbsp;&nbsp; Itraconazole</p><p>&ndash;&nbsp;&nbsp;&nbsp; Prasugrel</p><p>&ndash;&nbsp; Sulfonamides</p><p>&ndash;&nbsp;&nbsp;&nbsp; Thiotepa: A strong inhibition of cyclophosphamide bioactivation by thiotepa in high-dose chemotherapy regimens has been reported when thiotepa was administered 1 hour prior to cyclophosphamide.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An increase of the concentration of cytotoxic metabolites may occur with:</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp; Allopurinol</p><p>&ndash;&nbsp;&nbsp;&nbsp; Chloral hydrate</p><p>&ndash;&nbsp;&nbsp;&nbsp; Cimetidine</p><p>&ndash;&nbsp;&nbsp;&nbsp; Disulfiram</p><p>&ndash;&nbsp;&nbsp;&nbsp; Glyceraldehyde</p><p>&ndash;&nbsp;&nbsp;&nbsp; Inducers of human hepatic and extrahepatic microsomal enzymes (e.g., cytochrome P450 enzymes): The potential for hepatic and extrahepatic microsomal enzyme induction must be considered in case of prior or concomitant treatment with substances known to induce an increased activity of such enzymes such as rifampin, phenobarbital, carbamazepine, phenytoin, St. John&rsquo;s wort, and corticosteroids.</p><p>&ndash;&nbsp;&nbsp;&nbsp; Protease inhibitors: Concomitant use of protease inhibitors may increase the concentration of cytotoxic metabolites. Use of protease inhibitor-based regimens was found to be associated with a higher incidence of infections and neutropenia in patients receiving cyclophosphamide, doxorubicin, and etoposide (CDE) than use of an NNRTI-based regimen.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ondansetron</p><p>&nbsp;</p><p>There have been reports of a pharmacokinetic interaction between ondansetron and high-dose cyclophosphamide resulting in decreased cyclophosphamide AUC.</p><p>&nbsp;</p><p><u>Pharmacodynamic Interactions and Interactions of Unknown Mechanism</u> <u>Affecting the Use of Cyclophosphamide</u></p><p>&nbsp;</p><p>Combined or sequential use of cyclophosphamide and other agents with similar toxicities can cause combined (increased) toxic effects.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased hematotoxicity and/or immunosuppression may result from a combined effect of cyclophosphamide and, for example</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp; ACE inhibitors: ACE inhibitors can cause leukopenia.</p><p>&ndash;&nbsp;&nbsp;&nbsp; Natalizumab</p><p>&ndash;&nbsp;&nbsp;&nbsp; Paclitaxel: Increased hematotoxicity has been reported when cyclophosphamide was administered after paclitaxel infusion.</p><p>&ndash;&nbsp;&nbsp;&nbsp; Thiazide diuretics</p><p>&ndash;&nbsp;&nbsp;&nbsp; Zidovudine</p><p>&ndash;&nbsp;&nbsp;&nbsp; Clozapine</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased cardiotoxicity may result from a combined effect of cyclophosphamide and, for example</p><p>&nbsp;</p><p>&ndash;&nbsp; Anthracyclines</p><p>&ndash;&nbsp; Cytarabine</p><p>&ndash;&nbsp; Pentostatin</p><p>&ndash;&nbsp; Radiation therapy of the cardiac region</p><p>&ndash;&nbsp; Trastuzumab</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased pulmonary toxicity may result from a combined effect of cyclophosphamide and, for example</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp; Amiodarone</p><p>&ndash;&nbsp;&nbsp;&nbsp; G-CSF, GM-CSF (granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor): Reports suggest an increased risk of pulmonary toxicity in patients treated with cytotoxic chemotherapy that includes cyclophosphamide and G-CSF or GMCSF.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased nephrotoxicity may result from a combined effect of cyclophosphamide and, for example</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp; Amphotericin B</p><p>&ndash;&nbsp;&nbsp;&nbsp; Indomethacin: Acute water intoxication has been reported with concomitant use of indomethacin.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in other toxicities</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp; Azathioprine: Increased risk of hepatotoxicity (liver necrosis)</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&ndash;&nbsp;&nbsp;&nbsp; Busulfan: Increased incidence of hepatic veno-occlusive disease and mucositis has been reported.</p><p>&ndash;&nbsp;&nbsp;&nbsp; Protease inhibitors: Increased incidence of mucositis.</p><p>&nbsp;</p><p><u>Other interactions</u></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Alcohol</p><p>&nbsp;</p><p>A reduced antitumor activity was observed in tumor-bearing animals during ethanol (alcohol) consumption and concomitant oral low-dose cyclophosphamide medication.</p><p>&nbsp;</p><p>In some patients, alcohol may increase cyclophosphamide-induced vomiting and nausea.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Etanercept</p><p>&nbsp;</p><p>In patients with Wegener&rsquo;s granulomatosis, the addition of etanercept to standard treatment, including cyclophosphamide, was associated with a higher incidence of non-cutaneous solid malignancies.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Metronidazole</p><p>&nbsp;</p><p>Acute encephalopathy has been reported in a patient receiving cyclophosphamide and metronidazole. Causal association is unclear.</p><p>&nbsp;</p><p>In an animal study, the combination of cyclophosphamide with metronidazole was associated with increased cyclophosphamide toxicity.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tamoxifen</p><p>&nbsp;</p><p>Concomitant use of tamoxifen and chemotherapy may increase the risk of thromboembolic complications.</p><p>&nbsp;</p><p><u>Interactions Affecting the Pharmacokinetics and/or Actions of Other Drugs</u></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bupropion</p><p>&nbsp;</p><p>Cyclophosphamide metabolism by CYP2B6 may inhibit bupropion metabolism.</p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coumarins</p><p>&nbsp;</p><p>Both increased and decreased warfarin effect have been reported in patients receiving warfarin and cyclophosphamide.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclosporine</p><p>&nbsp;</p><p>Lower serum concentrations of cyclosporine have been observed in patients receiving a combination of cyclophosphamide and cyclosporine than in</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>patients receiving only cyclosporine. This interaction may result in an increased incidence of graft-versus-host disease.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depolarizing muscle relaxants</p><p>&nbsp;</p><p>Cyclophosphamide treatment causes a marked and persistent inhibition of cholinesterase activity. Prolonged apnea may occur with concurrent depolarizing muscle relaxants (e.g., succinylcholine). If a patient has been treated with cyclophosphamide within 10 days of general anesthesia, the anesthesiologist should be alerted.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digoxin, &beta;-acetyldigoxin</p><p>&nbsp;</p><p>Cytotoxic treatment has been reported to impair intestinal absorption of digoxin and &beta;-acetyldigoxin tablets.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vaccines</p><p>&nbsp;</p><p>The immunosuppressive effects of cyclophosphamide can be expected to reduce the response to vaccination. Use of live vaccines may lead to vaccine- induced infection.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Verapamil</p><p>&nbsp;</p><p>Cytotoxic treatment has been reported to impair intestinal absorption of orally administered verapamil</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>&nbsp;</p><p>Cyclophosphamide is contraindicated in pregnancy (see section 4.3). Cyclophosphamide crosses the placental barrier. Treatment with cyclophosphamide has a genotoxic effect and may cause foetal damage when administered to pregnant women. Both women and men should wait at least 6 to 12 months after stopping Cyclophosphamide before attempting to conceive or father a child.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Malformations have been reported in children born to mothers treated with cyclophosphamide during the first trimester of pregnancy. However, there are also reports of children without malformations born to women exposed during the first trimester.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exposure to cyclophosphamide in utero may cause miscarriage, foetal growth retardation, and foetotoxic effects manifesting in the newborn, including leukopenia, anaemia, pancytopenia, severe bone marrow hypoplasia, and gastroenteritis.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Animal data suggest that an increased risk of failed pregnancy and malformations may persist after discontinuation of cyclophosphamide as long as oocytes/follicles exist that were exposed to cyclophosphamide during any of their maturation phases. See Section 4.4, Genotoxicity.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If cyclophosphamide is used during pregnancy, or if the patient becomes pregnant while taking this drug or after treatment (see Section 4.4, Genotoxicity), the patient should be apprised of the potential hazard to a foetus.</p><p>&nbsp;</p><p><u>Breastfeeding</u></p><p>&nbsp;</p><p>Cyclophosphamide is passed into the breast milk. Neutropenia, thrombocytopenia, low hemoglobin, and diarrhoea have been reported in children breast fed by women treated with cyclophosphamide. Women must not breastfeed during treatment with cyclophosphamide.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>&nbsp;</p><p>Cyclophosphamide interferes with oogenesis and spermatogenesis. It may cause sterility in both sexes.</p><p>&nbsp;</p><p>Development of sterility appears to depend on the dose of cyclophosphamide, duration of therapy, and the state of gonadal function at the time of treatment.</p><p>&nbsp;</p><p>Cyclophosphamide-induced sterility may be irreversible in some patients.</p><p>&nbsp;</p><p>Sexually active women and men should use effective methods of contraception during these periods of time.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Female patients</p><p>&nbsp;</p><p>Amenorrhea, transient or permanent, associated with decreased oestrogen and increased gonadotrophin secretion develops in a significant proportion of women treated with cyclophosphamide.</p><p>&nbsp;</p><p>For older women, in particular, amenorrhea may be permanent.</p><p>&nbsp;</p><p>Oligomenorrhea has also been reported in association with cyclophosphamide treatment.</p><p>&nbsp;</p><p>Girls treated with cyclophosphamide during prepubescence generally develop secondary sexual characteristics normally and have regular menses.</p><p>&nbsp;</p><p>Girls treated with cyclophosphamide during prepubescence subsequently have conceived.</p><p>&nbsp;</p><p>Girls treated with cyclophosphamide who have retained ovarian function after completing treatment are at increased risk of developing premature menopause (cessation of menses before age of 40 years).</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Male patients</p><p>&nbsp;</p><p>Men treated with cyclophosphamide may develop oligospermia or azoospermia, which are normally associated with increased gonadotrophin but normal testosterone secretion.</p><p>&nbsp;</p><p>Sexual potency and libido generally are unimpaired in these patients.</p><p><!--[if gte vml 1]><v:group id="_x0000_s1026"
 style='position:absolute;left:0;text-align:left;margin-left:206.75pt;
 margin-top:480.8pt;width:85.2pt;height:25.6pt;z-index:-251656192;
 mso-position-horizontal-relative:page;mso-position-vertical-relative:page'
 coordorigin="4135,9616" coordsize="1704,512">
 <v:group id="_x0000_s1027" style='position:absolute;left:4135;top:9616;
  width:1704;height:260' coordorigin="4135,9616" coordsize="1704,260">
  <v:shape id="_x0000_s1028" style='position:absolute;left:4135;top:9616;
   width:1704;height:260' coordorigin="4135,9616" coordsize="1704,260" path="m4135,9616r1704,l5839,9875r-1704,l4135,9616xe"
   fillcolor="#f5f5f5" stroked="f">
   <v:path arrowok="t"/>
  </v:shape></v:group><v:group id="_x0000_s1029" style='position:absolute;
  left:4135;top:9868;width:1328;height:260' coordorigin="4135,9868"
  coordsize="1328,260">
  <v:shape id="_x0000_s1030" style='position:absolute;left:4135;top:9868;
   width:1328;height:260' coordorigin="4135,9868" coordsize="1328,260" path="m4135,9868r1327,l5462,10127r-1327,l4135,9868xe"
   fillcolor="#f5f5f5" stroked="f">
   <v:path arrowok="t"/>
  </v:shape></v:group><w:wrap anchorx="page" anchory="page"/>
</v:group><![endif]--></p><p>Boys treated with cyclophosphamide during prepubescence may develop secondary sexual characteristics normally, but may have oligospermia or azoospermia.</p><p>&nbsp;</p><p>Some degree of testicular atrophy may occur.</p><p>&nbsp;</p><p>Cyclophosphamide-induced azoospermia is reversible in some patients, though the reversibility may not occur for several years after cessation of therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients undergoing treatment with cyclophosphamide may experience undesirable effects (including, e.g., dizziness, blurred vision, visual impairment) which could affect the ability to drive or use machines. The decision to drive or operate machinery should be made on an individual basis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ADR frequency is based upon the following scale: Very Common (&ge;1/10); Common (&ge;1/100 - &lt;1/10), Uncommon (&ge;1/1,000 - &lt;1/100), Rare (&ge;1/10,000 - &lt;1/1,000),</p><p>Very Rare (&lt;1/10,000), Unknown (adverse reactions reported in the post-marketing experience)</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td colspan="3" style="vertical-align:top"><p><strong>Preferred term</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td colspan="3" style="vertical-align:top"><p>Infections1 Pneumonia2&nbsp;Sepsis1</p><p>Septic shock</p></td><td style="vertical-align:top"><p>Common Uncommon Uncommon Not Known</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Neoplasms benign, malignant and unspecified (incl cycts and polyps)</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Acute leukemia3</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>Rare Rare Rare Rare</p><p>Not known</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Myelodysplastic syndrome Secondary tumours Bladder cancer</p><p>Tumour lysis syndrome</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td colspan="3" style="vertical-align:top"><p>Myelosuppression 4</p><p>Haemolytic uraemic syndrome</p><p>Disseminated intravascular coagulation (DIC ) Lymphopenia</p></td><td style="vertical-align:top"><p>Very common Very common Very rare</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td colspan="3" style="vertical-align:top"><p>Immunosuppression Anaphylactic/Anaphylactoid reaction Hypersensitivity reaction</p></td><td style="vertical-align:top"><p>Very common Very rare Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p></td><td colspan="3" style="vertical-align:top"><p>SIADH</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td colspan="3" style="vertical-align:top"><p>Anorexia Dehydration Hyponatraemia Fluid retention</p><p>Blood glucose changes (increase or decrease)</p></td><td style="vertical-align:top"><p>Uncommon Rare</p><p>Very rare Very rare Not known</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td colspan="3" style="vertical-align:top"><p>Confusion</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td colspan="3" style="vertical-align:top"><p>Dizziness Convulsion Neurotoxicity5&nbsp;Encephalopathy</p></td><td style="vertical-align:top"><p>Rare Very rare</p><p>Unknown Unknown</p></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Preferred term</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Conjunctivitis Eye Oedema</p><p>Visual impairment Lacrimation increased</p></td><td style="vertical-align:top"><p>Very Rare Very Rare Rare</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>Deafness Tinnitus</p></td><td style="vertical-align:top"><p>Not known Not known</p></td></tr><tr><td rowspan="11" style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Ventricular fibrillation</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Ventricular tachycardia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cardiogenic shock</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Pericardial effusion</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Myocardial infarction</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac failure</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cardiomyopathy</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Myocarditis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Pericarditis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Electrocardiogram QT prolonged</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Arrhythmias6</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Flushing</p></td><td style="vertical-align:top"><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Pulmonary embolism</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Venous thrombosis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Vasculitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Peripheral ischaemia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic</p></td><td style="vertical-align:top"><p>Pulmonary veno-occlusive disease</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>and mediastinal</p></td><td style="vertical-align:top"><p>Acute respiratory distress syndrome (ARDS)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="10" style="vertical-align:top"><p>disorders</p></td><td style="vertical-align:top"><p>Interstitial Lung Diseases7</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Pulmonary hypertension</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Pulmonary oedema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Bronchospasm</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Dyspnea</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hypoxia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cough</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Nasal congestion</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Rhinorrhea</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Oropharyngeal pain</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Enterocolitis haemorrhagic Acute pancreatitis</p><p>Mucosal ulceration Stomatitis Diarrhoea Vomiting Constipation Nausea</p><p>Gastrointestinal Haemorrhage Colitis</p><p>Enteritis Cecitis</p><p>Abdominal pain</p><p>Parotid gland inflammation</p></td><td style="vertical-align:top"><p>Very rare Very rare Very rare Very rare Very rare Very rare Very rare Very rare Unknown Unknown Unknown Unknown Unknown Unknown</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p>Hepatobiliary disorders</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hepatic function abnormal</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Veno-occlusive disorder</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hepatitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cholestasis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hepatotoxicity8</p></td><td style="vertical-align:top"><p>Not known</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Preferred term</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous</p></td><td style="vertical-align:top"><p>Alopecia</p></td><td style="vertical-align:top"><p>Very common</p></td></tr><tr><td rowspan="15" style="vertical-align:top"><p>tissue disorders</p></td><td style="vertical-align:top"><p>Rash</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Dermatitis</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Discoloration of the palms, fingernails, soles</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Toxic epidermal necrolysis</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Stevens Johnson syndrome</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Erythema multiforme</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Palmar-plantar erythrodysaesthesia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Radiation recall dermatitis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Erythema in irradiated area</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus (including inflammatory itching)</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Erythema</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Urticaria</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Blisters</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Facial swelling</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Hyperhidrosis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and</p></td><td style="vertical-align:top"><p>Rhabdomyolysis</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>connective tissue</p></td><td style="vertical-align:top"><p>Scleroderma</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>disorders</p></td><td style="vertical-align:top"><p>Muscle spasms</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Myalgia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Cystitis Microhematuria Haemorrhagic cystitis Macrohematuria Suburethral bleeding</p><p>Oedema of the bladder wall</p><p>Interstitial inflammation, fibrosis, and sclerosis of bladder</p><p>Renal failure</p><p>Blood creatinine increased Renal tubular necrosis Renal tubular disorder Nephropathy toxic Hemorrhagic ureteritis Cystitis ulcerative</p><p>Bladder contracture Nephrogenic diabetes insipidus</p><p>Atypical urinary bladder epithelial cells Blood urea nitrogen increased</p></td><td style="vertical-align:top"><p>Very common Very common Common Common</p><p>Very rare Very rare Very rare</p><p>&nbsp;</p><p>Very rare Very rare Unknown Unknown Unknown Unknown Unknown Unknown Unknown Unknown Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Pregnancy, puerperium and perinatal conditions</p></td><td style="vertical-align:top"><p>Premature labour</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Impairment of spermatogenesis Ovulation disorder Amenorrhoea9</p><p>Azoospermia9&nbsp;Oligospermia9&nbsp;Infertility</p><p>Ovarian Failure Oligomenorrhoea, Testicular atrophy</p><p>Blood oestrogen decreased Blood gonadotrophin increased</p></td><td style="vertical-align:top"><p>Common Uncommon Rare</p><p>Rare Rare</p><p>Unknown Unknown Unknown Unknown Unknown Unknown</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Preferred term</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr><tr><td style="vertical-align:top"><p>Congenital, familial</p></td><td style="vertical-align:top"><p>Intra-uterine death</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>and genetic disorders</p></td><td style="vertical-align:top"><p>Fetal malformation</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Fetal growth retardation</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Fetal toxicity (including</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>myelosuppression/gastroenteritis)</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Fever Asthenia</p><p>Mucosal inflammation Chest pain</p><p>Headache</p><p>Injection/infusion site reactions10&nbsp;Multiorgan failure</p><p>Oedema</p><p>Influenza-like illness</p><p>General physical deterioration</p></td><td style="vertical-align:top"><p>Very common Common Common</p><p>Rare</p><p>Very Rare Not known Not known Not known Not known Not known</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Blood lactate hydrogenase increased C-reactive protein increased</p></td><td style="vertical-align:top"><p>Not known Not known</p></td></tr></tbody></table><p>&nbsp;</p><p>1 including other bacterial, fungal, viral, protozoal, parasitic, reactivation of latent infections, including viral hepatitis, tuberculosis, JC virus with progressive multifocal leucoencephalopathy (including fatal outcomes), Pneumocystis jiroveci, herpes zoster, Strongyloides</p><p>2&nbsp; &nbsp;including fatal outcomes</p><p>3 including acute myeloid leukemia, acute promyelocytic leukemia</p><p>4 manifested as Bone marrow failure, Pancytopenia, Neutropaenia, Agranulocytosis, Granulocytopenia,Thrombocytopaenia (complicated by bleeding), Leukopenia, Anaemia</p><p>5 manifested as reversible posterior leukoencephalopathy syndrome, myelopathy, peripheral neuropathy, polyneuropathy,neuralgia, dysesthesia, hypoesthesia, paresthesia, tremor, dysgeusia, hypogeusia,parosmia.</p><p>6 manifested as Atrial fibrillation,Supraventricular arrhythmia ,Ventricular arrhythmia, Bradycardia, Tachycardia,Palpitation</p><p>7 manifested by pulmonary fibrosis, obliterative bronchiolitis, organizing pneumonia, alveolitis allergic, pneumonitis</p><p>8 Hepatic failure, Hepatic encephalopathy, Ascites, Hepatomegaly, Jaundice, Blood bilirubin increased, Hepatic enzymes increased (ASAT, ALAT, ALP, gamma-GT)</p><p>9 persistent</p><p>10 manifested by thrombosis, necrosis, phlebitis, inflammation, pain, swelling, erythema.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Reporting of suspected adverse reactions</strong></p><p><strong>&nbsp;</strong></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system as per following contact details:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; Saudi Arabia:</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; Other GCC States:</p><table border="1" cellspacing="0" cellpadding="0" style="width:588px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Serious consequences of overdosage include manifestations of dose dependent toxicities such as myelosuppression, urotoxicity, cardiotoxicity (including cardiac failure), veno-occlusive hepatic disease, and stomatitis. See Section 4.4.</p><p>&nbsp;</p><p>Patients who received an overdose should be closely monitored for the development of toxicities, and haematotoxicity in particular.</p><p>&nbsp;</p><p>No specific antidote for cyclophosphamide is known.</p><p>&nbsp;</p><p>Cyclophophamide and its metabolites are dialysable. Consider haemodialysis in cases of severe overdose presenting early, particularly in patients with renal impairment</p><p>&nbsp;</p><p>Overdosage should be managed with supportive measures, including appropriate, state-of-the-art treatment for any concurrent infection, myelosuppression, or other toxicity, should it occur.</p><p>&nbsp;</p><p>Cystitis prophylaxis with mesna may be helpful in preventing or limiting urotoxic effects with cyclophosphamide overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide has been demonstrated to have a cytostatic effect in many tumour types.&nbsp; The active metabolites of cyclophosphamide are alkylating agents which transfer alkyl groups to DNA during the process of cell division, thus preventing normal synthesis of DNA.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide is well absorbed following an oral dose with a mean half-life of 4-8 hours for both oral and parenteral administration.</p><p>&nbsp;</p><p>It is an inactive pro drug with alkylating metabolites produced by hepatic metabolism, reaching peak levels 4-6 hours after an iv injection. Hepatic enzymes may be induced. The parent compound binds poorly to plasma protein but the active metabolites are significantly protein-bound. The drug is widely distributed and crosses the blood-brain barrier, the placental barrier and is found in ascites. The metabolites are excreted renally.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no pre-clinical data of relevance to the prescriber which are additional to the information already stated in other sections of the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet: Maize starch, lactose monohydrate, calcium hydrogen phosphate dihydrate, talc, magnesium stearate, gelatine, glycerol (85%).</p><p>&nbsp;</p><p>Coating: Sucrose, titanium dioxide, calcium carbonate, talc, macrogol 35000, silica colloidal anhydrous, povidone, sodium carboxymethylcellulose, polysorbate 20, montan glycol wax.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C. Store in original container.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>50 Tablets per carton box: 10 tablets in a PVC/aluminium blister strip and 10 blister strips in a box.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide is a cytotoxic agent.&nbsp; The handling of cyclophosphamide should always be in accordance with current guidelines on safe handling of cytotoxic agents.</p><p>&nbsp;</p><p>The coating of the tablets prevents direct contact of persons handling the tablets with the active substance. To prevent inadvertent exposure of third persons to the active substance, the tablets should not be divided or crushed.</p><p>&nbsp;</p><p>The tablets should not be handled by women who are pregnant or who are breast feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Oncology GmbH
Kantstraße 2
33790 Halle, Germany

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                9 December 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>